Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Apr 27th, 2026

LECO_Weekly-Healthcare-News_4-27-2026Download
  1. Eli Lilly (NYSE: LLY) to Acquire Ajax Therapeutics for Up to $2.3B to Advance Myelofibrosis and Polycythemia Vera Pipeline. Eli Lilly (LLY) has entered into a definitive agreement to acquire Ajax Therapeutics, gaining its lead next-generation Type II JAK2 inhibitor AJ1-11095, currently in Phase 1 for myelofibrosis. The total consideration could reach $2.3 billion, including upfront payment and clinical/regulatory milestones. The acquisition continues Lilly’s aggressive oncology buildout and targets patients who have progressed on existing JAK inhibitors. Lilly plans to rapidly advance AJ1-11095 into later-stage trials leveraging its hematology expertise. (Link)
  2. IKS Health Announces Agreement to Acquire TruBridge (NASD: TBRG) for ~$391–565 M. IKS Health has entered into a definitive agreement to acquire TruBridge, Inc., a leading provider of revenue cycle management (RCM) and electronic health record (EHR) solutions for rural and community hospitals. TruBridge shareholders will receive $26.25 per share in cash. The deal combines IKS Health’s agentic AI and care enablement capabilities with TruBridge’s deep expertise serving over 1,500 rural providers, creating a stronger platform for more than 2,000 healthcare organizations and 150,000 clinicians. The transaction is expected to close in Q3 2026, subject to shareholder and regulatory approvals. (Link)
  3. Ligand Pharmaceuticals (NASD: LGND) to Acquire XOMA Royalty for $739M. Ligand (LGND) has agreed to acquire XOMA Royalty (XOMA) for $39.00 per share in cash, representing an equity value of approximately $739 million, plus a contingent value right tied to ongoing litigation proceeds. The transaction expands Ligand’s royalty portfolio to over 200 assets and adds seven new commercial products. The deal is expected to be immediately accretive to Ligand’s earnings and further cements its position as a leading biopharma royalty aggregator. Closing is anticipated in Q3 2026. (Link)
  4. Thermo Fisher Scientific (NYSE: TMO) Agrees to Sell Microbiology Business to Astorg for Approximately $1.08 B. Thermo Fisher (TMO) has signed a definitive agreement to divest its microbiology business to private equity firm Astorg for ~$1.075 billion in cash plus a $50 million seller note. The business provides antimicrobial susceptibility testing and culture media products used in clinical, pharmaceutical, and food safety applications. The transaction is expected to close in the second half of 2026 and will be dilutive to Thermo Fisher’s adjusted EPS by $0.15 in the first full year post-close. (Link)
  5. Invidia Capital Makes Growth Capital Investment in WIN, a Leading Fertility and Family-Building Benefits Platform. Invidia Capital Management, a newly formed healthcare-focused private equity firm, has signed its first investment — a growth capital deal in WIN Holding Corporation, a leading fertility and family-building benefits provider. WIN serves over 900,000 families with a clinical-first model covering fertility treatment, surrogacy, adoption, maternity, menopause, and return-to-work programs. The investment is subject to regulatory approvals; WIN’s founder and CEO Dr. Roger Shedlin will continue leading the company. (Link)
  6. CVC Capital Partners and GTCR are reportedly exploring a take-private acquisition of Teleflex Incorporated (NYSE: TFX) as private equity interest in large-scale medical device manufacturers intensifies Global private equity firms CVC Capital Partners and GTCR are weighing a potential take-private deal for Teleflex Incorporated (TFX), a prominent manufacturer of medical devices for vascular and interventional access. This multi-billion dollar interest reflects a trend where private equity seeks to acquire large, cash-generative public medical technology companies. Teleflex (TFX) is viewed as an attractive target due to its diversified product portfolio and strong global market position. Investors are watching closely as a successful deal would require a significant premium over current trading prices. If the acquisition proceeds, CVC and GTCR would likely focus on operational restructuring and product line expansion to maximize the company’s long-term value in a private setting. (Link)
  7. Clearlake Capital-Backed ModMed (Modernizing Medicine) Acquires Bonsai Health, an Agentic AI Patient Engagement Platform, with Support from Financial Sponsors Project A Ventures, CPP Investments, and Golub Capital ModMed, a leading provider of cloud-based EHR software for specialty medical practices, has acquired Bonsai Health to bolster its AI-powered practice management capabilities. Backed by Clearlake Capital Group (with over $185 billion in AUM), along with co-sponsors Project A Ventures, CPP Investments, and Golub Capital, ModMed plans to deploy Bonsai’s agentic AI technology across its network of nearly 50,000 specialty providers in dermatology, ophthalmology, orthopedics, and gastroenterology. Bonsai’s platform automates patient reactivation and self-scheduling via multi-channel SMS and email without manual staff intervention. The acquisition brings former PatientPop co-founders Travis Schneider and Luke Kervin into the ModMed fold. Financial terms were not disclosed. (Link)
  8. Covera Health and Medmo have merged to create a unified data-driven platform focused on improving diagnostic imaging quality and patient access across the healthcare systemThe merger of Covera Health and Medmo creates a powerful new player in the diagnostic services market, combining Covera’s quality-analytics with Medmo’s navigation platform. This strategic combination is designed to ensure that patients are directed to high-quality imaging centers, reducing the incidence of misdiagnosis. Investors are backing this merger as it addresses the $100 billion problem of radiology inefficiency. The combined entity will leverage its data assets to partner with health plans and large employers, offering a value-based imaging solution. This deal highlights the investment trend of merging “access” platforms with “quality” analytics to create a more comprehensive health-tech solution that reduces overall payer costs. (Link)
  9. Oura has acquired Galen AI to integrate advanced metabolic health tracking and artificial intelligence capabilities into its market-leading wearable health platform. Oura has completed the acquisition of Galen AI, a strategic move that brings advanced artificial intelligence and metabolic health expertise into the Oura ecosystem. This investment is part of Oura’s transition from a wellness-focused ring to a clinical-grade health monitoring tool. By integrating Galen AI’s technology, Oura plans to offer users deeper insights into their metabolic data, potentially tracking glucose trends and other vital markers. (Link)
  10. Advanced RevCycle, via its financial sponsors Kolos Partners and Perkin Industries, completed a leveraged buyout of Select RCM Services and Select Health to expand its AI-driven revenue cycle management footprint. Advanced RevCycle has successfully executed a leveraged buyout of Select RCM Services and its specialized division, Select Health AI. This acquisition is strategically backed by financial sponsors Kolos Partners and Perkin Industries, who are providing the necessary capital to scale AI-driven billing and claims processing solutions. By integrating Select Health AI’s proprietary algorithms, Advanced RevCycle aims to reduce administrative friction for healthcare providers, a sector that investors see as ripe for automation-led growth. The deal reflects the ongoing investment thesis that specialized RCM platforms can achieve higher margins through the deployment of autonomous financial workflows. (Link)
  11. Aqua Dermatology, backed by financial sponsors Gryphon Investors, GTCR, and Athyrium Capital Management, has acquired Steele Dermatology Private equity heavyweights Gryphon Investors, GTCR, and Athyrium Capital Management continue to support the expansion of Aqua Dermatology through the strategic acquisition of Steele Dermatology. This leveraged buyout allows Aqua Dermatology to absorb a premium clinical practice into its platform, leveraging the sponsors’ deep expertise in healthcare service roll-ups. The investment is focused on scaling Aqua’s geographic presence and centralizing administrative functions to improve clinical throughput. Investors view the dermatology sector as a resilient asset class, where consolidating independent practices under a well-funded corporate umbrella creates significant value through purchasing power and standardized care protocols. (Link)
  12. Parkview Dental Partners, via its financial sponsors Barings, Barings Capital Investment BDC, and Cathay Capital, has acquired VIP Dental through a leveraged buyout on April 23, 2026, to scale its comprehensive and emergency dental care network. Parkview Dental Partners has expanded its reach in Florida by acquiring VIP Dental, a deal facilitated by a leveraged buyout with backing from Barings and Cathay Capital. The financial sponsors are providing the capital to integrate VIP Dental’s emergency and general dentistry services into Parkview’s broader Dental Service Organization (DSO) model. Investors like Barings Capital Investment BDC are particularly interested in the dental sector due to its recurring revenue and the opportunity for operational consolidation. By providing VIP Dental with professional management resources and advanced imaging technologies, the sponsors aim to drive organic growth and capture a larger share of the regional dental market. (Link)
  13. AdvaHealth has acquired the FlexView platform from Radical Imaging to launch AdvaView, a new cloud-native enterprise imaging and PACS solution for medical providers. AdvaHealth’s acquisition of FlexView from Radical Imaging represents a major strategic investment in the medical imaging software market. By acquiring this technology, AdvaHealth is launching “AdvaView,” a solution designed to provide healthcare systems with more flexible, cloud-based Picture Archiving and Communication Systems (PACS). The investment focuses on the growing need for interoperability and remote access to diagnostic data. Investors in the med-tech space are increasingly backing “asset-light” software solutions that can replace legacy on-premise hardware. AdvaHealth aims to use this acquisition to position itself as a leader in digital diagnostics, providing a scalable platform that improves radiologist efficiency and patient data security. (Link)
  14. Primary Health Solutions has announced a definitive agreement to acquire South Community Behavioral Health to expand its integrated mental and behavioral health services. Primary Health Solutions is investing in the expansion of its behavioral health footprint through the acquisition of South Community Behavioral Health. This deal reflects the growing investor interest in “whole-person care” models that integrate primary medical services with mental health support. By acquiring this regional provider, Primary Health Solutions aims to meet the surging demand for behavioral therapy while streamlining clinical workflows. The acquisition is expected to create significant synergies by allowing for a more coordinated approach to patient management. This transaction underscores the high value of community-based behavioral health assets as essential pillars for diversified organizations looking to thrive under value-based care contracts. (Link)

Venture Deals and Other

  1. Tava Health has raised $40 M in a Series C funding round led by Centana Growth Partners, with participation from Catalyst Investors, Blue Heron Ventures, Peterson Ventures, and Springtide Ventures. Tava Health has secured $40 million in Series C financing to expand its mental health platform, which connects individuals with specialized clinical care. The round was led by Centana Growth Partners and included a strong syndicate of investors such as Catalyst Investors and Peterson Ventures. This investment will enable Tava Health to grow its provider network and enhance its tech-enabled platform, which focuses on delivering high-quality mental health outcomes for employees and health plan members. Investors are drawn to Tava’s focus on provider satisfaction and clinical results, which have driven its rapid adoption by large corporations. This funding round underscores the continued strength of the mental health tech sector as a top priority for venture capital. (Link)
  2. Seaport Therapeutics Files for $212 M IPO (NASD: SPTX). Seaport Therapeutics, a clinical-stage biotech focused on novel antidepressants and anxiety treatments, is seeking to raise up to $212.4 million by offering 11.8 million shares priced between $16 and $18 each. The Boston-based company, a PureTech Health-founded entity, targets a ~$912 million valuation at the top of the range. Proceeds will advance its neuropsychiatric pipeline. This marks one of the more notable biotech IPOs of 2026. (Link)
  3. Nervonik Raises $52.5 M in Series B to Advance Peripheral Nerve Stimulation Therapy. Nervonik, a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system for chronic pain, announced a $52.5 million Series B round. The funding will support clinical studies, regulatory clearance, and commercialization of its next-generation miniaturized technology. This round builds on the company’s prior $13 million Series A and reflects continued investor enthusiasm for innovative neuromodulation solutions. (Link)
  4. TMRW Life Sciences has raised $38.359 M in new funding to expand its automated and digitized platform for the management of frozen specimens in the fertility industry. TMRW Life Sciences has secured over $38 million in a recent funding round, as detailed in SEC filings, to accelerate the global adoption of its automated cryo-management platform. TMRW’s technology replaces manual processes in IVF clinics with a digitized tracking and storage system for eggs and embryos, significantly reducing the risk of specimen loss or error. This investment reflects the strong venture interest in the fertility sector, where technology is increasingly used to bring scale and safety to complex lab environments. The capital will support TMRW’s commercial expansion and product development, as more clinics seek to modernize their operations to meet the rising global demand for IVF services, making TMRW an essential infrastructure partner. (Link)
  5. Zocalo Health has closed a $15 million Series A round led by EO Ventures, with participation from Talipot, Vamos Ventures, Animo Ventures, Acumen America, Sorenson Ventures, BarronKent, and Kapor Center. Zocalo Health has raised $15 million in Series A funding to scale its community-based primary care model for Latino populations. Led by EO Ventures, the round included a diverse group of investors like Vamos Ventures and Acumen America, who are focused on health equity and underserved markets. Zocalo Health uses a “trust-based” model that combines community health workers with a specialized technology platform to drive better health outcomes. This investment will be used to expand Zocalo’s footprint and clinical teams, addressing the critical need for culturally competent care. Investors see Zocalo’s approach as a blueprint for high-impact, value-based primary care that can successfully engage high-need populations who have been historically overlooked by traditional healthcare systems. (Link)
  6. Amperos Health has raised $16 million in a Series A round led by Bessemer Venture Partners, with participation from Uncork Capital and Neo, to scale its AI-native revenue recovery platform. Amperos Health, a developer of AI-native software for medical denial management, has secured $16 million in Series A funding. The round was led by Bessemer Venture Partners, a firm known for its investments in high-growth SaaS and AI companies. Uncork Capital and Neo also joined the round, signaling strong institutional support for Amperos’ “agentic” AI approach to revenue cycle management. The capital will be used to expand the company’s engineering team and accelerate the deployment of its platform, which automates the complex insurance appeal process. Investors are betting that Amperos can significantly reduce administrative overhead for hospitals, capturing a massive market opportunity in healthcare’s inefficient financial back-office. (Link)
  7. Coral has secured $12.5 million in funding led by Z47 and Lightspeed to accelerate the growth of its innovative healthcare fintech and payment processing solutions. Fintech startup Coral has raised $12.5 million in a new funding round led by prominent venture firms Z47 and Lightspeed. The investment is aimed at transforming the healthcare payment landscape by providing a more transparent and user-friendly billing platform for both providers and patients. Coral’s technology integrates with clinical workflows to simplify collections and insurance processing, a sector where investors see immense potential for disruption. Coral plans to scale its sales and marketing efforts and further develop its product features. Lightspeed’s involvement underscores the high confidence in Coral’s ability to solve the long-standing friction in medical billing, creating a more efficient financial ecosystem for the healthcare industry. (Link)
  8. Cerracap Ventures has invested in Nephronomics to accelerate the development of its AI-driven discovery platform for chronic kidney disease. Nephronomics has received a strategic investment from Cerracap Ventures to advance its groundbreaking AI platform, which focuses on identifying early biomarkers for chronic kidney disease (CKD). The platform uses proprietary algorithms to help pharmaceutical companies and clinicians discover new therapeutic targets, a field that investors see as having massive commercial potential. This capital will support Nephronomics’ efforts to validate its findings and expand its clinical partnerships. Cerracap Ventures’ investment reflects the growing interest in precision medicine and AI-led diagnostics for complex diseases. By funding the development of this discovery engine, investors aim to transform the standard of care for millions of CKD patients worldwide, moving toward earlier and more effective interventions. (Link)
  9. Capital QR Ventures has invested in Mia Health as the company launches a new funding round to support its digital health and patient wellness platform expansion. Mia Health has received a strategic investment from Capital QR Ventures to fuel its growth in the digital wellness and personalized health insights market. This funding is part of a broader round aimed at enhancing Mia Health’s data analytics capabilities and expanding its user base. Investors like Capital QR Ventures are backing Mia Health due to its ability to leverage biometric data to provide actionable health recommendations to consumers. The capital will be used to develop new features and strengthen the platform’s integration with healthcare providers, positioning Mia Health as a key player in the preventative care space. This transaction reflects the ongoing venture trend of investing in tech-driven wellness solutions that prioritize long-term health outcomes. (Link)
  10. Gravity Rail has raised $2.75 million in seed funding from Redesign Health to launch its AI-powered patient engagement platform for automated healthcare workflows. Gravity Rail has officially launched with $2.75 million in seed capital provided by Redesign Health. The startup’s platform offers a model-agnostic operating system that allows healthcare organizations to build and manage their own AI-powered patient communications. This investment is part of Redesign Health’s strategy to back innovative infrastructure that empowers medical providers to take control of their digital interactions. Gravity Rail’s technology enables clinical teams to automate tasks across multiple channels without writing code, ensuring consistent patient engagement and compliance. Investors view Gravity Rail as a vital tool for health systems looking to scale their operations while maintaining high standards of clinical communication and patient safety. (Link)
  11. Magicare has emerged from stealth with $3.6 million in pre-seed funding to develop its agentic operating system for the healthcare and pharmaceutical sectors. Magicare has secured $3.6 million in pre-seed capital to build a specialized AI operating system designed for the complex needs of the healthcare and pharmaceutical industries. This early-stage investment will support the development of autonomous AI agents that can manage operational workflows, from clinical trials to patient administration. Magicare’s focus on building a secure, compliant OS is particularly attractive to investors who see a gap in the market for AI that can function within highly regulated environments. This deal highlights the growing venture interest in “agentic” AI that moves beyond simple chatbots into true task-oriented automation. (Link)
  12. Dentscape and Preteeth AI Pro expect to receive $0.2 million in funding from ASO to advance their collaborative development of AI-driven dental diagnostic technologies. Dentscape and Preteeth AI Pro are set to receive a strategic $0.2 million investment from ASO to further their joint efforts in AI dental imaging and diagnostics. This funding is focused on enhancing the accuracy of automated diagnostic tools, allowing dentists to better identify and communicate oral health issues to patients. While an early-stage investment, it highlights the growing role of AI in dental specialty services. Investors are increasingly backing niche AI applications that can improve clinical precision and office productivity. Dentscape and Preteeth AI Pro aim to use this capital to refine their diagnostic algorithms, ultimately positioning their technology as a standard tool for modern dental practices seeking to improve patient outcomes and trust. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Apr 20th, 2026

LECO_Weekly-Healthcare-News_4-20-2026Download

Healthcare Weekly News and Deals –April 20th, 2026

  1. White House Issues Executive Order to Accelerate Medical Treatments for Serious Mental Illness, with Focus on Psychedelic Research and Patient Access. The White House announced an executive order directing federal agencies to accelerate the research, development, and regulatory review of innovative treatments for serious mental illness, with particular emphasis on psychedelic compounds such as ibogaine for treatment-resistant cases. The order instructs the FDA to issue National Priority Vouchers for Breakthrough Therapy-designated psychedelic drugs, facilitates patient access under the Right to Try Act (including Schedule I substances), and allocates at least $50 million through ARPA-H for state partnerships and clinical trial support. It also calls for enhanced collaboration and data sharing with the VA, plus expedited rescheduling reviews for qualifying substances post-Phase 3. The action aims to address the mental health crisis impacting over 14 million U.S. adults and elevated suicide rates among veterans by promoting treatments offering enduring therapeutic benefits beyond traditional medications. (Link)
  2. McKesson (NYSE: MCK) Signs Agreement with Apollo Funds for $1.25 Billion Strategic Minority Interest in Medical-Surgical Solutions Business. McKesson Corporation (MCK) has entered into an agreement with Apollo Funds for a $1.25 billion investment in convertible preferred equity, representing an approximately 13% minority stake in its Medical-Surgical Solutions (MMS) business at a ~$13 billion enterprise valuation. McKesson will retain majority ownership, operating control, and financial consolidation of the unit. The transaction represents a key milestone in McKesson’s planned separation and future IPO of MMS, which supplies essential products and solutions to non-acute care settings. Apollo’s expertise in carve-outs is expected to support MMS as a well-capitalized standalone company. The deal remains subject to regulatory approvals. (Link)
  3. Global Medical Response (NYSE: GMRS) Files S-1 Registration Statement in Advance of Planned IPO. Global Medical Response (GMR Solutions Inc.) has filed an S-1 registration statement with the SEC for an initial public offering of Class A common stock on the NYSE under the symbol GMRS. The company, the largest U.S. provider of emergency medical services (EMS) and integrated alternate-site care, operates air and ground ambulances across approximately 1,400 counties and serves about 5.5 million patients annually with roughly 34,000 employees. For 2025, GMR reported net revenue of approximately $5.74 billion and Adjusted EBITDA of $1.19 billion. (Link)
  4. Eli Lilly (NYSE: LLY) Acquires Texas ADC Specialist CrossBridge Bio in ~$300 Million Deal to Strengthen Oncology Pipeline. Eli Lilly (LLY) has acquired Houston-based CrossBridge Bio, a preclinical antibody-drug conjugate (ADC) specialist, in a transaction valued at approximately $300 million (mix of upfront and milestones). CrossBridge’s technology, originating from the University of Texas Health Science Center, features advanced linker stability and multi-payload capabilities, with lead TROP2-targeting dual-payload candidate CBB-120 expected to enter the clinic in 2026. The deal further builds on Lilly’s recent ADC acquisitions and internal efforts, enhancing its position in next-generation cancer therapies. (Link)
  5. UCB to Acquire Neurona Therapeutics for Up to $1.15 Billion, Advancing Epilepsy Pipeline with Regenerative Cell Therapy. UCB has agreed to acquire Neurona Therapeutics, gaining its lead asset NRTX-1001, a pluripotent stem cell-derived neuronal cell therapy currently in Phase I/II trials for drug-resistant mesial temporal lobe epilepsy (mTLE). The total transaction value reaches up to $1.15 billion, including $650 million upfront and up to $500 million in potential milestones. The acquisition advances UCB’s leadership in epilepsy by introducing regenerative science approaches aimed at restoring neural circuitry and providing durable seizure control. NRTX-1001 has received FDA RMAT and EMA PRIME designations. The deal is expected to close by the end of Q2 2026, subject to antitrust clearance. (Link)
  6. Organon (NYSE: OGN) Shares Surge Following Reports of Acquisition Interest from Leading Private Equity Firms CVC Capital Partners and TPG. Organon (OGN) witnessed a 25% increase in its stock price amid market reports that CVC Capital Partners and TPG are exploring a potential multi-billion dollar acquisition of the company. The interest from these prominent private equity firms highlights the perceived value in Organon’s diverse portfolio of women’s health products, biosimilars, and established brands. While a formal deal has not been confirmed, the involvement of CVC and TPG suggests a significant investment opportunity in the pharmaceutical space, as financial sponsors look for stable, cash-flow-generative assets. Investors are keeping a close watch on OGN as potential bidding activities could reshape the women’s health sector. (Link)
  7. Avanos Medical, Inc. (NYSE: AVNS) Agrees to $1.272 Billion Acquisition by American Industrial Partners to Transition the Company into Private Ownership. Avanos Medical, Inc. (AVNS) has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) for approximately $1.272 billion in an all-cash transaction. AIP’s investment values Avanos at $25.00 per share, representing a significant premium for stockholders. The deal will transition Avanos into a private entity, allowing the company to focus on long-term growth and its innovation roadmap without public market pressures. AIP intends to leverage its deep operational expertise to enhance Avanos’s competitive position in the medical technology sector. The acquisition is expected to close in the second half of 2026, marking a new chapter for the medtech firm. (Link)
  8. Gyde Acquires Benavest, Marking Its Second Deal in Two Weeks as AI-Enabled Health Insurance Brokerage Expands. Gyde, an AI-powered health insurance brokerage platform that launched in January 2026 with $60 million in funding, has acquired Benavest, a national agency specializing in consumer health plans including individual ACA, ICHRA, and Medicare products. The deal follows Gyde’s recent acquisition of Medicare brokerage Avid Health. Benavest brings scalable distribution infrastructure and leadership expertise, which Gyde plans to support with its AI-driven GydeOS platform. No financial terms were disclosed. (Link)
  9. Signant Health, Supported by Financial Sponsors Harvest Partners, Genstar Capital, and Foresite Capital, Enters into a Definitive Agreement to Acquire Ametris. Signant Health has signed a definitive agreement to acquire Ametris, a global leader in digital health solutions, with the backing of private equity firms Harvest Partners, Genstar Capital, and Foresite Capital. This acquisition integrates Ametris’s clinical trial data management and sensor technologies into Signant’s evidence-generation platform. The move is a strategic play by the financial sponsors to consolidate the eClinical technology market, creating a more comprehensive suite of tools for pharmaceutical sponsors. By acquiring Ametris, Signant Health aims to enhance its capabilities in capturing high-quality clinical evidence across virtual, hybrid, and traditional trial models globally. (Link)
  10. BTX Precision, via Financial Sponsors L Squared Capital Partners and CFT Capital Partners, Completes the Strategic Acquisition of Maitland Engineering. BTX Precision has acquired Maitland Engineering to expand its precision manufacturing platform, supported by financial sponsors L Squared Capital Partners and CFT Capital Partners. This acquisition follows a series of strategic moves by BTX, including a recent continuation vehicle led by L Squared and backed by HarbourVest Partners. The investment in Maitland Engineering strengthens BTX Precision’s capabilities in producing complex, high-tolerance components for the medical and aerospace industries. L Squared Capital Partners continues to drive the platform’s buy-and-build strategy, focusing on integrating specialized regional manufacturers to create a dominant, national high-precision engineering entity with significant operational scale. (Link)
  11. CPIhealth, Supported by Financial Sponsor Iron Path Capital, Acquires Midwest Interventional Spine Specialists and Serenity Surgical Center. CPIhealth, a portfolio company of private equity firm Iron Path Capital, has acquired Midwest Interventional Spine Specialists (M.I.S.S.) and Serenity Surgical Center. This acquisition adds two clinical locations and an ambulatory surgery center to CPIhealth’s interventional pain management platform, expanding its presence in the Indiana and Illinois markets. Iron Path Capital’s investment facilitates the integration of five additional physicians and multiple nurse practitioners into the platform. This deal underscores the firm’s strategy of consolidating regional pain management practices to build a multi-state infrastructure capable of delivering advanced, cost-effective interventional spine care through a standardized clinical and administrative model. (Link)
  12. Brado AI Strengthens its Conversational Engagement Platform Through the Strategic Acquisition of ProviderIQ from Hatchleaf. Brado AI has acquired the ProviderIQ asset from Hatchleaf to enhance its precision routing and patient-provider matching capabilities. This acquisition allows Brado AI to integrate clinically informed data and real-world operational workflows into its Conversational Engagement Platform (CEP). By acquiring the technology co-developed with clinicians from Johns Hopkins, Brado AI is investing in more accurate demand-supply alignment for large healthcare systems. The deal reflects Brado AI’s commitment to reducing patient leakage and optimizing provider utilization. The investment highlights a growing trend of AI companies acquiring specialized clinical data tools to provide deeper insights and better ROI for health system partners. (Link)
  13. D2 Solutions Acquires PromodRx to Expand Patient Access and Engagement Technologies for Pharmaceutical and Medical Device Manufacturers. D2 Solutions has completed the acquisition of PromodRx, a cloud-based platform designed to accelerate patient access to prescription medications. This strategic investment expands D2 Solutions’ service offerings in market access, reimbursement support, and patient engagement. By integrating PromodRx’s technology, D2 Solutions strengthens its UltraTouch Verify and Engage platforms, helping pharmaceutical clients navigate complex prior authorization and benefit verification processes. The acquisition is intended to reduce therapy initiation delays and improve patient adherence, positioning D2 Solutions as a more comprehensive commercialization partner in an increasingly complex pricing and policy environment within the life sciences sector. (Link)
  14. H2 Health, a Portfolio Company of Grant Avenue Capital, Expands into Arkansas Through the Strategic Acquisition of Advanced Physical Therapy. H2 Health, backed by private equity firm Grant Avenue Capital, has acquired Advanced Physical Therapy (APT), a practice with six locations in the Little Rock, Arkansas market. This investment marks H2 Health’s expansion into a new state, bringing its total footprint to over 300 clinics across 13 states. Grant Avenue Capital continues to provide the financial resources for H2 Health’s aggressive buy-and-build strategy in the outpatient rehabilitation sector. The acquisition of APT allows H2 Health to leverage its centralized administrative infrastructure to improve operational efficiencies at the local level while expanding access to high-quality physical and occupational therapy services. (Link)
  15. Afterburner Capital and Council Capital Successfully Exit Their Investment in Advanced Care Partners Following an Eight-Year Growth Period. Private equity firms Afterburner Capital and Council Capital have announced the successful exit of their portfolio company, Advanced Care Partners (ACP). During their eight-year investment period, the sponsors helped ACP scale its pediatric and adult private duty nursing services across Georgia and Florida. The exit represents a significant milestone for Afterburner and Council Capital, who focused on professionalizing ACP’s management and clinical infrastructure to drive growth. This transaction highlights the strong investor demand for home-based care platforms that provide high-quality services to medically fragile populations, as financial sponsors seek exits that demonstrate successful clinical and operational scaling in the healthcare services market. (Link)
  16. Stellus Rx, a Portfolio Company of WindRose Health Investors, Acquires Tria Health to Create an Integrated Pharmacist-Led Chronic Care Platform. Stellus Rx, which is backed by WindRose Health Investors, has acquired Tria Health to expand its pharmacist-led pharmacy care management capabilities. This acquisition merges Stellus Rx’s dispensing solutions with Tria Health’s chronic condition support services for self-insured employers. WindRose Health Investors is supporting this combination to create a differentiated platform that reduces the total cost of care through improved medication adherence and clinical outcomes. The investment underscores WindRose’s strategy of backing companies that deliver cost-effective healthcare solutions. The unified entity aims to leverage shared data and clinical expertise to better manage complex patients across the healthcare continuum. (Link)
  17. Mobia Medical (MOBI) Files for a $100 Million Initial Public Offering Led by BofA Securities, J.P. Morgan, and Goldman Sachs to Advance its Vagus Nerve Stimulation Technology. Mobia Medical (MOBI), a developer of neurostimulation devices for chronic stroke recovery, has filed with the SEC to raise up to $100 million in an initial public offering. The IPO process is being led by joint bookrunners BofA Securities, J.P. Morgan, and Goldman Sachs, alongside BTIG and Wolfe | Nomura Alliance. The company, which generated $32 million in revenue in 2025, intends to use the proceeds to expand its commercial organization and fund further R&D for its Vivistim system. This filing signals a major step for the venture-backed company as it transitions into the public markets to capitalize on the $30 billion stroke recovery sector. (Link)

Venture Deals and Other

  1. Avo (AvoMD) Secures $10 Million Series A Funding Led by Noro-Moseley Partners with Participation from AlleyCorp, Las Olas Venture Capital, MedMountain Ventures, Epsilon Health, Scrub Capital, Dunamu & Partners, Mirae Asset Capital, and Futureplay. Avo (formerly AvoMD) has successfully closed a $10 million Series A funding round to advance its AI-powered clinical decision support platform. The round was led by Noro-Moseley Partners, featuring a broad syndicate of investors including AlleyCorp, Las Olas Venture Capital, MedMountain Ventures, Epsilon Health, and Scrub Capital. International support came from Korean firms Dunamu & Partners, Mirae Asset Capital, and Futureplay. The capital will be utilized to scale Avo’s generative AI copilots within major EHR systems, helping clinicians integrate real-time medical knowledge and hospital protocols directly into their digital workflows to improve patient outcomes. (Link)
  2. Bain Capital Life Sciences Backs Beeline Medicines with $300 Million in Capital to Develop Five Clinical Programs Acquired from Bristol Myers Squibb (BMY). Beeline Medicines has emerged from stealth with a massive $300 million investment commitment from Bain Capital Life Sciences. The venture-backed biotech is focused on advancing a portfolio of five clinical-stage programs originally discovered by Bristol Myers Squibb (BMY), targeting autoimmune and inflammatory diseases. This strategic investment allows Beeline to accelerate late-stage clinical development for assets like afimetoran, a TLR7/8 inhibitor. Bain Capital’s funding provides the necessary runway for Beeline to operate as an agile, clinical-stage entity, leveraging established pharmaceutical intellectual property to address significant unmet needs in the immunology and gastrointestinal sectors. (Link)
  3. Pulnovo Medical Announces Oversubscribed $100 Million Financing Round with Strategic Investment from Medtronic. Pulnovo Medical, a pioneer in innovative therapies for pulmonary hypertension, closed an oversubscribed $100 million financing round featuring a strategic investment from Medtronic. The capital will support the advancement of Pulnovo’s clinical programs and commercialization efforts for its pulmonary artery denervation technology. This marks a significant vote of confidence from one of the world’s leading medtech companies in the growing field of interventional pulmonary hypertension treatments. (Link)
  4. Joyful Health Raises $17 Million in Series A Funding Led by CRV with Support from XYZ Venture Capital, Designer Fund, Inflect Capital, and Go Global Ventures. Joyful Health, an AI-driven financial infrastructure provider for the healthcare industry, has secured $17 million in Series A funding. The investment was led by CRV, with participation from XYZ Venture Capital, Designer Fund, Inflect Capital, and Go Global Ventures. The company plans to use this capital to expand its workforce and accelerate the development of its “financial operating system,” which helps healthcare providers automate revenue cycle management and recover unpaid insurance claims. The investors highlighted Joyful Health’s ability to leverage AI to identify processing breakdowns and prioritize high-value recovery opportunities for resource-constrained medical practices. (Link)
  5. Keebler Health Announces $16 Million Series A Investment Led by Flare Capital Partners and Sands Capital to Expand AI Capabilities for Unstructured Clinical Data. Keebler Health has closed a $16 million Series A round led by Flare Capital Partners, with significant participation from Sands Capital. The funding will scale Keebler’s LLM-native platform, which is designed to unlock insights from unstructured clinical documentation—such as provider notes and imaging reports—to improve risk adjustment and value-based care accuracy. Investors noted that Keebler’s technology addresses a critical gap in the market where 80% of patient data remains underutilized. This capital injection will support team expansion and the deployment of real-time clinical insights aimed at enhancing both financial performance and patient outcomes for healthcare systems. (Link)
  6. Worki Secures $2.75 Million in Pre-Seed Funding Led by Founders Fund and Y Combinator to Scale its Healthcare Recruitment and Workforce Management Platform. Healthcare staffing startup Worki has raised $2.75 million in a pre-seed round led by Founders Fund and Y Combinator. The investment targets the growing labor crisis in healthcare by providing a mobile-first platform that simplifies recruitment and scheduling for both providers and facilities. Founders Fund and Y Combinator are backing Worki’s mission to reduce industry reliance on expensive third-party staffing agencies through a more streamlined, automated hiring process. The new capital will be used to enhance the platform’s AI-driven matching capabilities and expand its reach across North American health systems struggling with nurse and technician shortages. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Apr 13th, 2026

LECO_Weekly-Healthcare-News-4-13-2026Download

Healthcare Weekly News and Deals –April 13th, 2026

  1. FunctionHealth, a longevity-focused health tech startup for at-home-accessible lab testing, has acquired mobile healthcare platform Getlabs to bring comprehensive diagnostic services directly to consumers’ homes. Function, a health-tech company focused on proactive wellness, has acquired Getlabs, the leader in nationwide at-home lab draws. This acquisition allows Function to integrate a physical service layer into its digital platform, enabling members to have blood work and other diagnostics performed in the comfort of their homes. The investment is aimed at removing the friction traditionally associated with laboratory testing. By owning the logistical infrastructure of Getlabs, Function can ensure a standardized, high-quality experience for its users, furthering its mission to empower individuals with deep health insights through regular and accessible testing. (Link)
  2. Havencrest Capital Management has completed a majority recapitalization of Offor Health to accelerate the expansion of its clinical delivery model. Havencrest Capital Management, a healthcare-focused private equity firm, has finalized a majority recapitalization of Offor Health. This investment is designed to provide the necessary growth capital for Offor Health to scale its unique model of delivering high-quality clinical care, particularly in the dental and specialized surgical spaces. Havencrest’s involvement will focus on enhancing the company’s operational infrastructure and geographic footprint. The investor views Offor Health as a disruptive force in office-based clinical services, and the capital infusion will support the company’s mission to increase patient access and reduce costs for specialized procedures. (Link)
  3. ESO, backed by financial sponsors Vista Equity Partners and JSL Health Capital, has successfully acquired d2i to accelerate emergency intelligence and improve outcomes across fire, EMS, and health systems. ESO, a leading data and software vendor for emergency medical services (EMS), fire departments, and hospitals, has finalized its acquisition of d2i. The investment, supported by PE firms Vista Equity Partners and JSL Health Capital, aims to integrate d2i’s advanced data analytics and performance management tools into ESO’s ecosystem. This move is designed to provide healthcare professionals with deeper insights into clinical and operational performance. The investors are focused on scaling ESO’s ability to drive better patient outcomes through real-time data intelligence across the continuum of care. (Link)
  4. Council Capital and PMPK have partnered to acquire MedicalServiceQuotes.com to expand their healthcare procurement and analytics platform capabilities. Council Capital, a healthcare-focused private equity firm, alongside PMPK, has acquired MedicalServiceQuotes.com (MSQ). The investment is intended to bolster MSQ’s position as a leading platform for healthcare procurement, providing transparency and efficiency in medical service sourcing. By integrating Council Capital’s deep industry expertise and PMPK’s strategic resources, the company plans to scale its analytics and procurement tools. The investors aim to capitalize on the growing demand for cost-containment solutions in the healthcare sector, helping providers and payers optimize their spend through a more streamlined, data-driven digital marketplace. (Link)
  5. Qualifacts Systems, supported by financial sponsors Warburg Pincus, Martis Capital Management, and Clanton Capital, has completed the acquisition of MethodOne to enhance its behavioral health technology offerings. Qualifacts, a leading provider of electronic health records (EHR) for behavioral health, has expanded its portfolio by acquiring MethodOne. The deal is backed by a powerful consortium of investors including Warburg Pincus, Martis Capital, and Clanton Capital. MethodOne specializes in comprehensive clinic management software for opioid treatment programs. The investors are betting on the consolidation of specialized behavioral health software to create a unified platform that addresses the complex regulatory and clinical needs of addiction treatment providers. This acquisition strengthens Qualifacts’ market position as a premier technology partner in the behavioral health and human services sectors. (Link)
  6. Bioness Medical, via its financial sponsor Accelmed, has acquired the Portable Neuromodulation Stimulator (PoNS) system to bolster its neuro-rehabilitation portfolio. Bioness Medical, a subsidiary supported by the private equity firm Accelmed, has successfully acquired the PoNS system, a non-invasive medical device used in neurological rehabilitation. Accelmed’s strategic investment is aimed at integrating this innovative technology into Bioness’s existing suite of rehabilitation solutions. The acquisition allows Bioness to offer a more comprehensive range of therapies for patients suffering from neurological symptoms due to disease or trauma. Accelmed plans to utilize its expertise in the medical device sector to drive the commercial adoption and clinical validation of the PoNS system in global markets. (Link)
  7. DAS Health, backed by financial sponsor Coalesce Capital, has expanded its national footprint through the acquisition of Prime Care Technologies and Prime Cloud from Prime Holdings. DAS Health, a leader in healthcare IT and management services, has acquired Prime Care Technologies and Prime Cloud. This transaction was facilitated by Coalesce Capital, which provides the strategic funding and guidance for DAS Health’s aggressive expansion strategy. The acquisition integrates advanced cloud hosting and post-acute care technology solutions into DAS Health’s portfolio, enhancing its service offerings for long-term care facilities. Coalesce Capital is focused on building DAS Health into a dominant national provider of healthcare technology solutions, leveraging the synergies between these entities to offer comprehensive, integrated services to a wider range of medical providers. (Link)
  8. Sidekick Therapy Partners, supported by financial sponsors Green Hills Partners and Hillandale Advisors, has acquired Word of Mouth Clinical Associates to broaden its therapy service delivery. Sidekick Therapy Partners, a provider of pediatric therapy services, has acquired Word of Mouth Clinical Associates. The deal is backed by Green Hills Partners and Hillandale Advisors, who are focused on consolidating the fragmented pediatric therapy market. By acquiring Word of Mouth, Sidekick expands its reach and clinical expertise in speech, occupational, and physical therapy. The investors are committed to supporting Sidekick’s growth through operational improvements and strategic bolt-on acquisitions. This move strengthens Sidekick’s ability to provide high-quality, multidisciplinary care to children and families while creating a larger, more efficient regional platform. (Link)
  9. Livtech has successfully acquired Alora Healthcare Systems to integrate advanced home health software into its technology ecosystem. Livtech, a prominent player in healthcare technology, has announced the acquisition of Alora Healthcare Systems. This strategic acquisition focuses on Alora’s specialized software solutions for home health agencies. The investment is intended to create a more robust, end-to-end platform for home-based care providers, streamlining clinical documentation, scheduling, and billing. By integrating Alora’s technology, Livtech aims to provide a seamless user experience for healthcare professionals operating outside of traditional hospital settings. The acquisition reflects the increasing investment interest in home health technology as the industry shifts toward decentralized, patient-centric care models. (Link)
  10. Vertex Pharmaceuticals (NASD: VRTX) has entered into a definitive agreement to acquire Alpine Immune Sciences (NASD: ALPN) for approximately $4.9 billion to bolster its immunology pipeline. Vertex Pharmaceuticals is set to acquire Alpine Immune Sciences in an all-cash deal, significantly expanding its presence in the immunology and immunotherapy space. The acquisition centers on Alpine’s lead candidate, povetacicept, a potential best-in-class treatment for various autoimmune diseases. Vertex is utilizing its strong balance sheet to invest in high-potential late-stage clinical assets that complement its existing focus on serious diseases. This multi-billion dollar investment underscores Vertex’s strategy of diversifying beyond cystic fibrosis and acquiring innovative platforms that can address significant unmet medical needs in the protein engineering and immunology sectors. (Link)
  11. MKH Capital Partners has acquired Haven Health Management to provide growth capital for its 22 treatment locations across the United States. MKH Capital Partners, a family-backed private equity firm, has completed the acquisition of Haven Health Management. The investment provides significant growth capital to support Haven Health’s operations across its 22 addiction and mental health treatment facilities. MKH Capital Partners intends to use its resources to expand Haven Health’s geographic footprint and enhance its clinical services. The investor sees a substantial opportunity in the behavioral health sector, focusing on improving patient access to evidence-based treatment for substance use disorders. This deal highlights the continued interest of private equity in scaling established behavioral health platforms. (Link)
  12. Gilead Sciences, Inc. (NASD: GILD) has announced the acquisition of Tubulis to add a next-generation antibody-drug conjugate (ADC) platform to its oncology pipeline. Gilead Sciences is acquiring Tubulis to gain access to its proprietary ADC technologies, which are designed to create more stable and effective cancer therapies. This strategic investment is part of Gilead’s ongoing effort to diversify its portfolio into oncology and become a leader in targeted cancer treatments. The acquisition includes Tubulis’s diverse pipeline of ADC candidates and its innovative conjugation platforms. Gilead intends to leverage its extensive clinical development and commercialization expertise to accelerate the progress of Tubulis’s candidates, further strengthening its position in the rapidly evolving and highly competitive ADC market. (Link)
  13. BPOC has completed the sale of Midwest Products Engineering (MPE), marking the conclusion of a successful investment period for the private equity firm. BPOC, a healthcare-focused private equity firm, has finalized the sale of Midwest Products Engineering (MPE). During BPOC’s ownership, MPE expanded its capabilities as a leading design and manufacturing partner for medical device OEMs. The firm’s investment supported MPE’s growth through operational enhancements and strategic initiatives, positioning it as a critical supplier in the medical equipment market. This exit demonstrates BPOC’s ability to build value within the medical manufacturing sector. While the buyer was not disclosed, the sale highlights the strong demand for specialized manufacturing firms that serve the high-growth medical device industry. (Link)
  14. Response BPO has joined Carenet Health to exponentially grow its U.S. healthcare impact through expanded operations in South Africa. Carenet Health, a provider of 24/7 healthcare engagement and clinical solutions, has acquired Response BPO. This investment is strategically aimed at leveraging Response BPO’s operational strength in South Africa to enhance Carenet Health’s service delivery for U.S.-based healthcare organizations. The acquisition allows Carenet to offer more cost-effective and scalable engagement solutions, including clinical support and member services. By integrating Response BPO, Carenet Health strengthens its global delivery model, ensuring high-quality, continuous support for its clients while expanding its international footprint in the competitive business process outsourcing market within the healthcare sector. (Link)
  15. Telcor has acquired Sample Healthcare to lead an AI-driven transformation of revenue cycle operations for healthcare providers. Telcor, a leader in laboratory revenue cycle management (RCM) and point-of-care testing software, has acquired Sample Healthcare. This investment is focused on integrating Sample Healthcare’s AI capabilities into Telcor’s existing RCM platform. The goal is to automate complex billing processes, reduce denials, and improve the financial performance of laboratories and health systems. The investors believe that applying AI to revenue cycle operations will significantly increase efficiency and accuracy in healthcare billing. This acquisition reinforces Telcor’s position as an innovator in the RCM space, providing its clients with advanced tools to navigate the complexities of healthcare reimbursement. (Link)
  16. Blackstone and TPG Capital have completed the multi-billion dollar acquisition of medical technology leader Hologic, Inc. (NASD: HOLX). Private equity giants Blackstone and TPG have finalized their acquisition of Hologic, a prominent developer of diagnostic products and medical imaging systems. This strategic move aims to leverage Hologic’s market leadership in women’s health and surgical products to drive further innovation and global expansion. The investors plan to support the company’s R&D initiatives and enhance its operational capabilities through their extensive network and capital resources. This acquisition reflects the ongoing interest of top-tier private equity firms in high-performing medical technology assets with steady revenue streams and significant growth potential in the global diagnostics market. (Link)
  17. Seaport Therapeutics, a PureTech Health (LSE: PRTC) founded entity, has filed for a U.S. Initial Public Offering (IPO) to fund the development of its neuropsychiatric pipeline. Seaport Therapeutics, established by the biotherapeutics company PureTech Health, has officially filed for an IPO in the United States. The company is focused on advancing a pipeline of novel neuropsychiatric medicines using its proprietary Glyph platform, which is designed to enhance the oral bioavailability of drugs. The IPO proceeds are intended to fund clinical trials and further research into treatments for depression, anxiety, and other central nervous system disorders. This move marks a significant milestone for Seaport and its founding investors, as they seek to transition from a venture-backed entity to a public company to access broader capital markets for long-term growth. (Link)
  18. APM Human Services International Limited (ASX: APM) has acquired WorkCare to expand its occupational health and workforce wellness solutions across the global health and human services market WorkCare, a leading provider of occupational health and incident management services, has been acquired by APM Human Services International Limited (ASX: APM). This strategic acquisition allows APM to significantly bolster its “Health and Wellbeing” service vertical, integrating WorkCare’s clinical expertise in medical surveillance, onsite clinics, and telehealth. The investment is focused on scaling WorkCare’s delivery model across the United States and international markets, leveraging APM’s global infrastructure. The deal reflects the investor’s objective to address the increasing demand for integrated, data-driven employee health solutions that reduce workplace injuries and improve organizational productivity on a global scale. (Link)

Venture Deals and Other

  1. Chapter has raised $100 million in a new funding round led by Addition and NFX to simplify the Medicare enrollment process for seniors. Chapter, a technology-driven Medicare advisor, has secured $100 million in growth capital to expand its platform. The round was led by venture capital firms Addition and NFX, with participation from other existing investors. This significant investment will be used to enhance Chapter’s proprietary technology, which helps seniors navigate the complexities of Medicare to find the best-fitting coverage. The investors are backing Chapter’s unique model that searches every available plan, unlike traditional brokers. The capital will also support the hiring of additional advisors and the expansion of the company’s reach to more seniors across the United States. (Link)
  2. HeyDonto has closed a $20 million Seed round at a $200 million valuation to scale Conduit, its innovative dental interoperability exchange platform. HeyDonto, an AI-focused dental technology startup, has raised $20 million in Seed funding from a group of strategic venture investors. The round values the company at $200 million, reflecting strong investor confidence in its Conduit platform. Conduit is designed to solve the long-standing problem of data silos in dentistry by providing a seamless interoperability exchange for patient records and clinical data. The investment will be used to accelerate product development and expand the company’s sales and marketing efforts. The investors aim to position HeyDonto as the central infrastructure for the modern, data-driven dental practice, improving efficiency and patient care. (Link)
  3. SimpliFed has raised over $10 million in an oversubscribed Series A round to expand its maternal health ecosystem and improve access to breastfeeding support. SimpliFed, a maternal health company, has successfully closed a Series A funding round exceeding $10 million. The oversubscribed round included participation from several venture capital firms focused on health-tech and female-founded businesses. SimpliFed provides virtual breastfeeding support and baby feeding guidance, covered by insurance. The new capital will be used to scale the company’s operations, partner with more health plans, and expand its team of clinical experts. Investors are particularly interested in SimpliFed’s ability to provide high-quality, accessible maternal care that improves long-term health outcomes for both mothers and infants while reducing overall healthcare costs. (Link)
  4. Luminai has raised $38 million in a Series B funding round to scale its intelligence platform across health system operations and administrative workflows. Luminai, a company specializing in operational intelligence for healthcare, has secured $38 million in Series B funding. The round was led by prominent venture capital firms looking to capitalize on the automation of healthcare administration. Luminai’s platform uses AI to streamline complex workflows within health systems, reducing the administrative burden on staff and improving operational efficiency. The investment will be used to expand the company’s product features and accelerate its market penetration among large health systems. The investors see Luminai as a key player in solving the staffing shortages and burnout issues currently plaguing the healthcare industry through smart automation. (Link)
  5. Yuzu Health, a next-generation third-party administrator (TPA) providing unified infrastructure for health insurance plans, has raised $35 million in Series A funding. The round was led by General Catalyst and Chemistry, with participation from Anthropic’s Anthology Fund and others. The platform enables customizable plan designs through white-labeled claims processing, payments, and member administration. Proceeds will expand the engineering team and automate manual workflows to scale nationally. Investors see Yuzu Health as a key modernizer of outdated  infrastructure. (Link)
  6. Jimini Health, a clinician-supervised AI platform for behavioral health, has raised $17 million in seed funding led by M13 and Town Hall Ventures. Its Sage assistant integrates into care teams with full clinician oversight and visibility. The capital will support enterprise partnerships, expand clinical capabilities, and deepen EHR integrations. Investors view Jimini Health as a safe, scalable solution to responsibly deploy AI in mental health while addressing risks of unsupervised tools. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Apr 6th, 2026

LECO_Weekly-Healthcare-News_4-6-2026Download

Healthcare Weekly News and Deals – April 6th, 2026

  1. Anthropic, backed by a $30 billion Series G, acquires stealth startup Coefficient Bio in a $400 million all-stock AI-biotech deal. AI leader Anthropic has acquired Coefficient Bio, a stealth-mode startup specializing in AI for biological research, in a transaction valued at approximately $400 million in stock. Coefficient Bio, founded just eight months ago by elite researchers from Genentech’s Prescient Design unit, was backed by the venture firm Dimension, which reportedly held a 50% stake in the company. The acquisition marks a significant vertical expansion for Anthropic, as the Coefficient team—including co-founders Nathan C. Frey and Samuel Stanton—will join its Healthcare and Life Sciences division. The deal aims to transform the Claude AI model into a specialized infrastructure for drug discovery and biopharma workflows, positioning Anthropic to compete directly with specialized AI-medicine firms in a market estimated to be worth over $100 B. (Link)
  2. Merit Medical (NASD: MMSI) strengthens oncology division with the strategic acquisition of Viewpoint Medical. Merit Medical (MMSI) has finalized its purchase of View Point Medical to expand its therapeutic oncology portfolio. The acquisition includes View Point’s steerable needle technology, which is critical for accessing difficult-to-reach tumors during biopsy and ablation procedures. This strategic tuck-in acquisition allows Merit to offer a more comprehensive suite of tools to interventional radiologists. Investors view this move as a way for Merit to maintain its growth trajectory in the high-value oncology market while utilizing its established sales force to drive rapid adoption of the new technology across global hospitals. (Link)
  3. Blackstone-backed AGS Health said to file for $500 million India IPO to capitalize on healthcare outsourcing demand. AGS Health, a leading provider of revenue cycle management services backed by private equity giant Blackstone, is reportedly filing for an Initial Public Offering (IPO) in India to raise approximately $500 million. This move allows Blackstone to partially exit its investment while providing AGS Health with the capital necessary to scale its technology-enabled services and global delivery model. The IPO highlights the robust investor appetite for healthcare IT outsourcing firms that utilize AI and automation to streamline clinical documentation and billing. By listing on the Indian exchanges, AGS Health aims to leverage its significant operational footprint in the region to attract both domestic and international institutional investors. (Link)
  4. Eli Lilly (NYSE: LLY) acquires Centessa Pharmaceuticals for $1.5 billion to advance sleep disorder treatments. Eli Lilly (LLY) has reached an agreement to acquire Centessa Pharmaceuticals in a deal valued at approximately $1.5 billion. The acquisition focuses on Centessa’s promising pipeline of orexin receptor agonists, which are being developed to treat narcolepsy and other sleep disorders. Lilly aims to leverage its global R&D infrastructure to accelerate these therapies through clinical trials. The deal reinforces Lilly’s commitment to expanding its neuroscience portfolio beyond Alzheimer’s and pain management. By acquiring Centessa, Lilly gains access to potentially best-in-class molecules that address a significant unmet need in the sleep medicine market. (Link)
  5. Quantum Health acquires CirrusMD while GE HealthCare (NASD: GEHC) completes acquisition of Intelerad. These deals highlight a massive shift toward integrated digital health ecosystems where navigation, virtual delivery, and diagnostic data management are seamlessly combined to improve patient outcomes and provider efficiency. (Link)
  6. Grovecourt Capital Partners portfolio company Premier Radiology Services acquires Global Imaging Solutions to bolster teleradiology subspecialty expertise. Premier Radiology Services has expanded its domestic footprint by acquiring Global Imaging Solutions. This deal, backed by Grovecourt Capital Partners, focuses on increasing the volume of subspecialty interpretations, such as musculoskeletal and neuroradiology, available to its clients. The acquisition comes at a time when the demand for remote diagnostic services is surging due to radiologist shortages. Premier Radiology aims to use this merger to provide faster turnaround times and higher-quality reports to rural hospitals and imaging centers that lack on-site specialists, reinforcing its position as a leading teleradiology provider. (Link)
  7. Office Ally, backed by Barings, Francisco Partners, and New Mountain Capital, acquires Jopari Solutions to scale electronic transaction processing. The acquisition expands Office Ally’s clearinghouse network by integrating Jopari’s capabilities in electronic billing, clinical attachments, and payment workflows. Together, the combined platform enhances interoperability and supports higher transaction volumes across provider and payer interactions. The deal strengthens Office Ally’s position in end-to-end healthcare transaction infrastructure. It also reflects a broader shift toward automation and streamlined administrative operations across the healthcare system. (Link)
  8. Jukebox Health acquires Braided Health to enhance AI-driven integrated care platforms for high-needs dual-eligible populations. Jukebox Health acquired Braided Health to expand its AI-driven integrated care platform for high-need, dual-eligible Medicare and Medicaid populations. The transaction combines Braided Health’s AI-powered care management technology with Jukebox’s in-home clinical services, enabling health plans to better identify risks and intervene earlier. By integrating care management workflows with real-time, in-home clinical insights, the platform aims to improve outcomes while reducing total cost of care for complex patient populations. (Link) 
  9. Community Health Systems (NYSE: CYH) completes divestiture of Huntsville-based Crestwood Medical Center. The transaction combines Braided Health’s AI-powered care management technology with Jukebox’s in-home clinical services, enabling health plans to better identify risks and intervene earlier. By integrating care management workflows with real-time, in-home clinical insights, the platform aims to improve outcomes while reducing total cost of care for complex patient populations. The combined platform strengthens Jukebox’s ability to serve dual-eligible Medicare and Medicaid populations at scale. The deal reflects a broader push to modernize legacy care management systems through data-driven, home-based interventions. (Link)
  10. Virtual care platform OpenLoop Health acquires nutrition-focused startup Season Health to expand clinical service offerings. The acquisition adds Season Health’s nutrition therapy capabilities to OpenLoop’s telehealth infrastructure, enabling more comprehensive care across chronic conditions and weight management programs. OpenLoop, which supports a range of virtual care providers including GLP-1 platforms, can now integrate dietitian-led services directly into its clinical workflows. The deal strengthens its ability to offer more complete, end-to-end virtual care solutions. It also reflects a broader trend of telehealth platforms expanding into lifestyle-based interventions to improve patient outcomes. (Link)
  11. Sentinel Capital Partners portfolio company Catalyst MedTech acquires X3D to expand advanced imaging service capabilities. Catalyst MedTech, formerly known as TTG Imaging Solutions and a portfolio company of Sentinel Capital Partners, has acquired X3D. This acquisition enhances Catalyst MedTech’s portfolio of diagnostic imaging services, particularly in the realm of specialized 3D imaging technology and maintenance. Sentinel Capital continues to support Catalyst’s aggressive buy-and-build strategy to create a dominant national player in the refurbished medical equipment and imaging service market. The integration of X3D is expected to provide Catalyst with deeper technical expertise and a broader customer base among hospitals and independent diagnostic centers.(Link)
  12. Gyde acquires Avid Health to launch AI-enabled Medicare brokerage platform and expand market footprint. Gyde has successfully acquired Avid Health, marking the launch of a new AI-enabled brokerage platform specifically designed for the Medicare market. The acquisition combines Gyde’s technology with Avid Health’s distribution network to streamline the plan selection process for seniors. By utilizing AI to analyze patient data and plan benefits, the new platform aims to increase transparency and match beneficiaries with optimal coverage. This deal reflects the increasing application of automation and artificial intelligence in the insurance brokerage space to simplify complex regulatory environments and improve consumer decision-making.(Link)
  13. LongueVue Capital and Swaney Group Capital partner to invest in Apex Dental Laboratory Group to drive regional expansion. Private equity firm LongueVue Capital has partnered with Swaney Group Capital to make a significant growth investment in Apex Dental Laboratory Group. Apex is a leading provider of dental lab services, and this capital infusion is intended to support the company’s buy-and-build strategy across the United States. The investors aim to leverage Apex’s digital dentistry capabilities to consolidate a fragmented market of local dental labs. This investment highlights the continued interest of PE firms in the dental services organization (DSO) and ancillary dental technology sectors, focusing on operational scaling through technology.(Link)
  14. Vision Innovation Partners acquires Frederick Eye Institute to expand ophthalmic surgical platform in the Mid-Atlantic. Vision Innovation Partners, a leading ophthalmic platform, has acquired Frederick Eye Institute, a multi-specialty ophthalmology practice. This acquisition further solidifies Vision Innovation Partners’ presence in the Mid-Atlantic region, adding significant clinical and surgical capacity. The firm continues to pursue a consolidation strategy, acquiring high-quality practices to provide integrated eye care services ranging from routine exams to complex surgeries. By joining the platform, Frederick Eye Institute will benefit from enhanced administrative support and access to advanced diagnostic technology, reflecting the ongoing private equity-led consolidation trend within the ophthalmology sector.(Link)

Venture Deals and Other

  1. WHOOP raises $575 million in Series G funding at a $10.1 billion valuation to scale its wearable health platform. The round includes participation from high-profile athletes and celebrities such as LeBron James, Cristiano Ronaldo, Rory McIlroy, and Shane Lowry, alongside institutional investors including Collaborative Fund, Mayo Clinic, Mubadala Investment Company, and Qatar Investment Authority. The capital will support expansion of its subscription-based wearable platform focused on sleep, recovery, and performance, while accelerating product development, enhancing data-driven health insights, and scaling its global membership base, with a continued push into broader health monitoring capabilities and long-term growth initiatives. (Link)
  2. Ambient Clinical Analytics raises $5 million and appoints Brian Tufts as CEO to scale AWARE clinical AI platform. Ambient Clinical Analytics has successfully closed a $5 million funding round aimed at scaling its AWARE platform, a clinical decision support tool designed to reduce medical errors in high-acuity settings like the ICU. Alongside the investment, the company named Brian Tufts as its new CEO to lead the commercial expansion. The funding will be used to integrate more advanced AI capabilities and expand the platform’s footprint in hospitals globally. Ambient’s technology focuses on real-time data visualization to help clinicians make faster, more accurate decisions, addressing the critical need for burnout reduction and improved patient safety. (Link)
  3. Jimini Health raises $17 million in venture funding to expand its AI-driven behavioral health platform. Jimini Health has secured $17 million in a new funding round to accelerate the growth of its AI-powered mental health platform. The investment will be directed toward expanding the company’s therapist network and enhancing its AI tools that assist in patient monitoring and personalized treatment planning. Jimini Health focuses on providing scalable, evidence-based behavioral care by combining human expertise with machine learning. This round reflects the continued venture capital appetite for AI solutions that address the global shortage of mental health professionals and provide more accessible care options for patients. (Link)
  4. Insight Health raises $11 million to scale clinical AI agents for automated healthcare administrative tasks. Insight Health has raised $11 million in venture capital to further develop and deploy its clinical AI agents. These agents are designed to automate routine administrative tasks for healthcare providers, such as documentation, scheduling, and billing queries. By offloading these burdens from clinical staff, Insight Health aims to reduce provider burnout and improve operational efficiency within hospital systems. The funding will support the expansion of the engineering team and the commercialization of the platform. This investment highlights the trend of “narrow AI” solving specific, high-friction problems in healthcare administration. (Link)
  5. Naver D2SF makes strategic investment in Soundable to advance AI-based respiratory health monitoring technology. Naver D2SF, the startup investment arm of South Korean tech giant Naver, has made a strategic investment in Soundable. Soundable specializes in AI-driven sound analysis technology that monitors respiratory health through cough and breathing patterns captured via smartphones. This investment is part of Naver’s broader strategy to expand its digital health ecosystem and integrate advanced diagnostic tools into its consumer platforms. The funds will help Soundable refine its algorithms and seek regulatory approvals in international markets. The deal underscores the rising interest in non-invasive, remote monitoring technologies that leverage everyday devices for health screening. (Link)
  6. Long Tail secures growth investment to expand its technology-driven healthcare solutions and market reach. Long Tail has announced a new growth investment aimed at scaling its technology platform. While the specific dollar amount was not disclosed, the funding will be used to enhance the company’s product development and expand its sales and marketing efforts. Long Tail focuses on providing specialized software solutions that help healthcare organizations manage “long tail” data and niche operational challenges. This investment reflects a growing interest from venture and growth equity firms in specialized SaaS platforms that address specific inefficiencies within the healthcare value chain, rather than broad, general-purpose software. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Mar 30th, 2026

LECO_Weekly-Healthcare-News_3-30-2026Download
  1. Abbott (NYSE: ABT) Completes Acquisition of Exact Sciences (NASDAQ: EXAS) Abbott (NYSE: ABT) has officially finalized its acquisition of Exact Sciences (NASDAQ: EXAS), a move aimed at bolstering its leadership in the cancer diagnostics and screening market. The integration of Exact Sciences’ flagship Cologuard technology into Abbott’s massive global diagnostics portfolio is expected to drive significant revenue growth and expand access to non-invasive screening tools. Investors are monitoring how this multibillion-dollar deal will impact Abbott’s long-term earnings per share. This strategic consolidation highlights the ongoing trend of medical device giants acquiring specialized biotech innovators to maintain a competitive edge in the preventive healthcare sector. (Link)
  2. Merck (NYSE: MRK) to Acquire Terns Pharmaceuticals (NASDAQ: TERN) for $53 Per Share in Cash Merck (NYSE: MRK) has entered into a definitive agreement to acquire Terns Pharmaceuticals (NASDAQ: TERN) for $53 per share in an all-cash transaction. This acquisition allows Merck to gain control of Terns’ promising pipeline of oncology and metabolic disease treatments, specifically focusing on small-molecule oral therapies. The premium price reflects investor confidence in Terns’ clinical data and the potential for these assets to offset upcoming patent expirations in Merck’s existing portfolio. The deal reinforces Merck’s aggressive M&A strategy to diversify its pipeline through high-value biotech acquisitions that offer immediate technological advantages and long-term market exclusivity. (Link)
  3. Infosys (NYSE: INFY) to Acquire US Firms Optimum Healthcare IT for $465 Million and Stratus for $95 Million Infosys (NYSE: INFY) is significantly expanding its footprint in the United States healthcare sector by acquiring Optimum Healthcare IT for $465 million and Stratus for $95 million. These investments are designed to enhance Infosys’ digital transformation capabilities, specifically within healthcare provider networks and cloud-based medical data management. By bringing these specialized consulting firms under the Infosys umbrella, the company aims to offer more robust, end-to-end IT solutions to American healthcare systems. Investors view this as a strategic deployment of capital to capture the growing demand for digital modernization and data interoperability within the heavily regulated healthcare industry. (Link)
  4. Cencora (NYSE: COR) to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business Cencora (NYSE: COR), formerly AmerisourceBergen, has announced a deal to acquire the retina-specific business of EyeSouth Partners to expand its Retina Consultants of America (RCA) platform. EyeSouth Partners is backed by Olympus Partners. This acquisition underscores Cencora’s commitment to specialized physician services, particularly in the high-growth ophthalmology sector. By integrating these practices, Cencora enhances its scale in clinical research and specialty distribution, providing a more comprehensive value proposition to manufacturers and patients alike. The investment reflects a broader private equity-style roll-up strategy within the specialty care market, aimed at optimizing operational efficiencies and expanding the company’s geographic reach across the United States. (Link)
  5. Efferent Acquired by Hopper OS via Financial Sponsor GPI Capital Through an LBO Efferent was acquired by Hopper OS on March 24, 2026, through a leveraged buyout (LBO) backed by financial sponsor GPI Capital. This acquisition is intended to integrate Efferent’s specialized technology into Hopper OS’s “intelligent healthcare operating system,” creating a more seamless data environment for providers. GPI Capital’s involvement indicates a strong private equity interest in the healthcare infrastructure space, focusing on companies that can automate clinical workflows. The undisclosed investment will facilitate the scaling of Efferent’s tools, allowing Hopper OS to offer a more robust, AI-enhanced suite of products to its global healthcare clientele. (Link)
  6. HealthTech Solutions Acquired by Health Management Associates via Financial Sponsor BPOC Through an LBO Health Management Associates (HMA) has completed the acquisition of HealthTech Solutions through a leveraged buyout supported by financial sponsor BPOC. The deal, finalized on March 27, 2026, aims to merge HMA’s Medicaid expertise with HealthTech’s advanced technological capabilities. BPOC’s investment highlights the private equity sector’s focus on Medicaid modernization and state-level healthcare IT. By acquiring HealthTech, HMA strengthens its ability to provide technical advisory services to government agencies. The undisclosed transaction is expected to drive growth by enabling HMA to manage complex data systems and improve health outcomes for vulnerable populations through better technology. (Link)
  7. Careflow Receives Growth Investment from Blueprint Equity to Expand Product Platform Careflow has secured an undisclosed amount of development capital from Blueprint Equity as of March 26, 2026. This strategic growth investment is earmarked for the expansion of Careflow’s product platform and the acceleration of its market penetration. Blueprint Equity’s participation marks a significant vote of confidence in Careflow’s software solutions for the healthcare industry. The capital infusion will allow the company to scale its operations and enhance its technological offerings, focusing on improving workflow efficiency for healthcare professionals. This deal exemplifies the active role of private equity in fostering the growth of mid-sized health-tech firms aiming for market leadership. (Link)
  8. Novartis to Acquire Excellergy in Up to $2B Deal to Expand Allergy Pipeline Novartis has agreed to acquire Excellergy, a U.S.-based biotech developing next-generation therapies for allergic diseases, in a deal worth up to $2 billion including milestone payments. The acquisition adds Excellergy’s lead asset, Exl-111, a next-generation anti-IgE antibody currently in early-stage clinical development, designed to deliver faster and more durable suppression of allergic responses. Exl-111 builds on the same biological pathway as Novartis’ blockbuster Xolair but is engineered to improve efficacy, dosing convenience, and overall disease control across multiple IgE-mediated conditions. The transaction is expected to close in the second half of 2026, pending regulatory approvals, further strengthening Novartis’ leadership in immunology and allergy therapeutics. (Link)
  9. PCSI Completes Acquisition of CareStarter and Feedback to Launch PCSIx Innovation Unit PCSI has finalized the acquisition of CareStarter and Feedback, two companies focused on patient engagement and care coordination. These acquisitions serve as the foundation for PCSI’s new innovation unit, PCSIx. The investment aims to bridge the gap between healthcare providers and patients by utilizing CareStarter’s resource platforms and Feedback’s communication tools. By consolidating these technologies, PCSI intends to streamline the patient journey and improve health literacy. This move signals a shift toward integrated, patient-centered care models, with the investor focusing on long-term value through improved patient outcomes and reduced administrative friction in the care delivery process. (Link)
  10. Collectly to Acquire Pledge Health to Accelerate AI Automation in Patient Finance Collectly has announced its acquisition of Pledge Health, a strategic move designed to integrate AI-driven automation into the patient financial experience. The acquisition focuses on streamlining medical billing and transparent pricing, addressing one of the most significant pain points in American healthcare. By combining forces, Collectly and Pledge Health aim to provide patients with clearer financial insights while helping providers increase collection rates through automated workflows. This investment highlights the growing market for fintech solutions within the healthcare sector, where AI is being leveraged to reduce manual errors and improve the overall transparency of healthcare costs. (Link)
  11. Vitality Acquires Ramp Health to Merge AI Behavioral Health and Workplace Safety Vitality has successfully acquired Ramp Health, aiming to create a comprehensive platform that merges AI-powered behavioral health services with workplace safety protocols. This acquisition is part of Vitality’s broader strategy to enhance corporate wellness programs by providing employers with data-driven tools to support employee mental and physical health. The integration of Ramp Health’s expertise allows Vitality to offer more personalized health interventions and preventative safety measures. Investors see this as a timely move, given the increasing corporate focus on employee well-being and the role of AI in delivering scalable health solutions in a professional environment. (Link)
  12. Palm Primary Care Acquires Two Clinics in Azle to Expand Local Access Palm Primary Care has expanded its clinical footprint by acquiring two primary care clinics in Azle, Texas. This investment is part of the company’s localized growth strategy, focusing on increasing access to high-quality primary care in suburban and rural areas. By acquiring established practices, Palm Primary Care can immediately serve an existing patient base while implementing its standardized care models and advanced technology systems. The deal reflects a continuing trend of consolidation in the primary care sector, where larger organizations acquire independent practices to achieve economies of scale and provide more integrated services to the local community. (Link)
  13. HealthDrive Corp Acquires Georgia Long-Term Care Consulting HealthDrive Corp, backed by Cressey & Company, has acquired Georgia Long-Term Care Consulting, expanding its reach into the specialized field of post-acute and long-term care services. This acquisition allows HealthDrive to strengthen its consultancy and on-site clinical service offerings for seniors in long-term care facilities. The investment is driven by growing demand for specialized medical services within the aging population. By integrating the Georgia-based firm, HealthDrive enhances its ability to manage complex care needs and regulatory compliance for long-term care facilities. This move reinforces HealthDrive’s position as a major player in the evolving landscape of senior healthcare services in the United States. (Link)
  14. Cerebral Acquires Inflow to Broaden Mental Health and ADHD Support Cerebral has acquired Inflow, a startup focused on digital tools for ADHD management, to broaden its behavioral health platform. This acquisition enables Cerebral to provide more specialized, non-clinical support for neurodivergent individuals, complementing its existing telepsychiatry services. The investment highlights Cerebral’s strategy to become a holistic provider of mental health solutions by incorporating self-management tools and community support into its clinical model. Investors are watching how this expansion into digital therapeutics will help Cerebral differentiate itself in a crowded telehealth market while improving long-term patient engagement and clinical outcomes for those with ADHD. (Link)
  15. Gilead Sciences to Acquire Ouro Medicines in $2.2B Deal to Expand Autoimmune Pipeline Gilead Sciences announced it will acquire Ouro Medicines in a transaction valued at up to approximately $2.2 billion, including $1.675 billion upfront and potential milestone payments. The deal centers on Ouro’s lead asset, a clinical-stage BCMAxCD3 T-cell engager designed to treat severe autoimmune diseases by targeting pathogenic B cells. Early data has shown promising efficacy and a differentiated safety profile, positioning the therapy as a potential “immune reset” approach. Strategically, the acquisition expands Gilead’s inflammation and immunology pipeline as it seeks to diversify beyond its core HIV franchise. (Link)
  16. RTW Investments Boosts Stake in Cogent Biosciences RTW Investments increased its position in U.S.-based Cogent Biosciences by purchasing over 4.1 million shares, representing an estimated $116 million investment and signaling strong conviction in the company’s pipeline. The stake now accounts for roughly 2.7% of RTW’s reportable assets, highlighting the importance of the position within its biotech-focused portfolio. Cogent is advancing precision therapies for genetically defined diseases, with key U.S. regulatory milestones, including an FDA decision expected in late 2026, acting as major value inflection points. The move reflects continued investor interest in U.S. biotech innovation, particularly companies nearing potential commercialization. (Link)
  17. GeBBS Healthcare Solutions Announces Acquisition of RND OptimizAR GeBBS Healthcare Solutions, Inc., a leading provider of technology-enabled Revenue Cycle Management (RCM) and Risk Adjustment Solutions for healthcare providers and payers, announced this morning the acquisition of RND OptimizAR, an India-based specialized provider of Revenue Cycle Management services focused on the Durable Medical Equipment (DME) and Home Medical Equipment (HME) market. The deal strengthens GeBBS’ capabilities in niche RCM segments. GeBBS is backed by global investors including EQT and ChrysCapital. (Link)
  18. Vision Innovation Partners Acquires Frederick Eye Institute Vision Innovation Partners (VIP), a leading Mid-Atlantic eye care platform with 69 locations and backed by Gryphon Investors, announced this morning the acquisition of Frederick Eye Institute, a comprehensive ophthalmology practice in Frederick, Maryland. This marks VIP’s 28th add-on acquisition since 2017 and further strengthens its presence in the key Maryland. (Link)
  19. AI Maverick Intel Announces LOI to Acquire HEAL Access Canada  The proposed acquisition would integrate HEAL’s AI-powered patient navigation and virtual care coordination platform into its ecosystem. The deal represents the first transaction under its Right of First Refusal agreement with HEAL. (Link)
  20. Monument MicroCap Partners Invests in Champion Wellness Centers to Support Growth and Expansion The investment supports Champion Wellness Centers, a Tampa-based provider of chiropractic and multidisciplinary wellness services. The company operates a network of clinics offering physical therapy, regenerative medicine, and other integrated treatments, positioning it to benefit from growing demand for holistic care. The partnership will support geographic expansion and add-on acquisitions. (Link)

Venture Deals and Other

  1. eMed Raises $200 Million Led by Aon, Including Participation from Tom Brady and Linda Yaccarino to Expand GLP-1 Access eMed has received a strategic investment from a high-profile group including Tom Brady and Linda Yaccarino to support its mission of expanding access to GLP-1 weight-loss medications. The funding will enhance eMed’s digital health platform, which provides clinical oversight and testing for patients seeking metabolic treatments. This investment reflects the massive market demand for weight-loss drugs and the role of telehealth in managing prescription distribution. The involvement of such prominent figures suggests a shift toward celebrity-backed healthcare ventures that aim to combine medical credibility with mass-market consumer appeal in the rapidly growing obesity-treatment sector. (Link)
  2. Adonis Raises $40 Million in Series C Funding to Transform Revenue Cycle Management Adonis has successfully closed a $40 million Series C funding round to accelerate the development of its AI-driven revenue cycle management platform. This significant capital infusion will be used to enhance the company’s automation capabilities, helping healthcare providers reduce administrative burdens and improve billing accuracy. The investment round reflects strong venture capital confidence in Adonis’s ability to solve complex financial inefficiencies within the healthcare system. With this new funding, Adonis plans to expand its engineering team and scale its go-to-market strategies, aiming to become the standard for financial operations in large-scale medical groups and health systems. (Link)
  3. Blossom Health Secures Series A Funding Led by Headline to Expand Telepsychiatry Services Blossom Health has raised a Series A investment round, with Headline serving as the lead investor. The funding is intended to scale Blossom Health’s telehealth and telepsychiatry platform, which focuses on providing accessible mental healthcare to underserved populations. Headline’s involvement brings both capital and strategic expertise in scaling consumer-facing digital health brands. Blossom Health plans to use the funds to hire more clinical staff and enhance its mobile application interface. This deal highlights the continued venture capital appetite for mental health startups that leverage technology to overcome traditional barriers to care, such as cost and geographic location. (Link)
  4. Dimer Health Raises $13.5 Million for AI-Driven Post-Discharge Care Platform Dimer Health has secured $13.5 million in funding to support its AI-driven platform designed to improve post-discharge patient care. The investment will be used to further develop technology that monitors patients after they leave the hospital, aiming to reduce readmission rates and improve recovery outcomes. By utilizing predictive analytics, Dimer Health helps clinicians identify high-risk patients who may need immediate intervention. This venture deal underscores the growing interest in “hospital-at-home” models and the use of artificial intelligence to bridge the gap between acute hospital stays and long-term recovery in a home setting. (Link)
  5. Gimlet Labs Raises $80 Million to Transform AI Inference Infrastructure Gimlet Labs has closed a substantial $80 million funding round aimed at transforming AI inference infrastructure. While not strictly a healthcare firm, its technology is pivotal for the future of AI-driven medical diagnostics and drug discovery. The investment will allow Gimlet Labs to scale its hardware and software solutions that make running complex AI models faster and more cost-effective. Venture capitalists are betting on Gimlet Labs to provide the foundational infrastructure that will power the next generation of AI applications across various sectors. This capital will be used for research and development and expanding their manufacturing capabilities to meet global demand. (Link)
Spenser Lin No Comments

Recently Released Industry Report: Food as Medicine (FaM): How Food is Becoming a Trusted Part of Modern Healthcare

FoodAsMedicine.FaM_March2026Download

Food as Medicine (FaM) is rapidly gaining traction among investors and healthcare leaders — moving from a wellness trend into a reimbursable, outcomes-driven part of the healthcare system.

In our newly released industry paper “Food as Medicine (FaM): How Food Is Becoming a Trusted Part of Modern Healthcare”, we break down the current market dynamics, highlight proven cost savings, explore expanding reimbursement pathways, and show where the strongest investment opportunities lie today.

This report gives investors, analysts, and healthcare stakeholders the clear, practical insights needed to understand and successfully engage with this fast-emerging sector.

Highlights Include:   

  • How everyday food can dramatically improve health outcomes and lower costs
  • What “Food as Medicine” really means — and why it’s moving into mainstream healthcare
  • Medically Tailored Meals: Clinical results and real per-patient savings
  • Medical Nutrition Therapy and the expanding role of registered dietitians
  • The growing role of registered dietitians and scalable telenutrition counseling
  • High-margin Prescription Grocery models that leverage existing retail networks
  • The Food-as-Medicine Intervention Pyramid — from broad prevention to intensive care
  • Expanding policy tailwinds and new reimbursement pathways
  • Market maps, recent acquisitions, venture deals, and where the best opportunities sit today
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Mar 23rd, 2026

LECO_Weekly-Healthcare-News_3-23-2026Download
  1. GE HealthCare (NASD: GEHC) Completes $2.3B Acquisition of Intelerad to Bolster Cloud-First Imaging Solutions GE HealthCare (NASDAQ: GEHC) has finalized its acquisition of Intelerad Medical Systems, a leading provider of enterprise imaging software. This strategic move is designed to accelerate GE HealthCare’s transition toward cloud-based enterprise solutions and “precision care.” By integrating Intelerad’s informatics platform, GE HealthCare aims to improve clinician workflows and data accessibility across hospital systems. The acquisition enhances the company’s digital health portfolio, focusing on scalable, interoperable imaging tools that reduce administrative burdens. This deal reflects the broader industry trend of medical technology giants acquiring software firms to dominate the healthcare data infrastructure market. (Link)
  2. Movano (NASD: MOVE) Completes All-Stock Merger with Corvex (NASD: CVEX) and Rebrands Movano Health (NASDAQ: MOVE) and Corvex have completed a strategic merger, creating a unified entity focused on AI-driven cloud infrastructure for healthcare. Movano, known for its wearable medical technology and the Evie Ring, will leverage Corvex’s cloud capabilities to enhance its data analytics and patient monitoring services. The merger aims to create a “cloud infrastructure powerhouse” capable of processing large-scale health data for clinical and consumer applications. This transaction reflects the merging of hardware and software capabilities in the wearable tech space to provide more comprehensive, actionable health insights through artificial intelligence. (Link)
  3. Knowtion Health Acquires Revly to Enhance RCM and AI-Driven Denial Management Management via its financial sponsors Arsenal Capital Partners, Sunstone Partners and Ardan Equity Knowtion Health, a leader in revenue cycle management (RCM) and claim denial resolution, has acquired Revly, an AI-powered billing technology company. Knowtion Health is a portfolio company of Sunstone Partners. This acquisition integrates Revly’s advanced automation into Knowtion’s existing platforms to help hospitals and health systems recover unpaid claims more efficiently. By combining human expertise with Revly’s AI, Knowtion aims to reduce the rising rate of insurance denials. This deal underscores the high demand for AI-driven solutions in the administrative healthcare space to combat labor shortages and complex payer requirements. (Link)
  4. Prestige Consumer Healthcare (NYSE: PBH) to Acquire Breathe Right from Foundation Consumer Healthcare Prestige Consumer Healthcare Inc. (NYSE: PBH) has signed a definitive agreement to acquire the Breathe Right nasal strip brand from Foundation Consumer Healthcare. This acquisition strengthens Prestige’s portfolio of leading over-the-counter consumer brands, specifically within the respiratory care segment. Breathe Right is the global leader in the nasal strip category, and this move is expected to be immediately accretive to Prestige’s earnings and free cash flow. The deal highlights Prestige’s ongoing strategy of acquiring established, high-growth consumer health brands to leverage its existing retail distribution network and marketing infrastructure. (Link)
  5. Pacific Avenue Capital Partners Completes Acquisition of Care.com from IAC (NASD: IAC) An affiliate of Pacific Avenue Capital Partners has completed the acquisition of Care.com from IAC (NASDAQ: IAC). Care.com is the world’s leading platform for finding and managing high-quality family care, including childcare, senior care, and specialized medical care. Under the new ownership of Pacific Avenue, the company plans to invest in product innovation and expand its enterprise offerings for employers. This private equity buyout signifies a shift for Care.com as it moves away from a conglomerate structure to focus on independent growth in the rapidly expanding digital caregiving marketplace. (Link)
  6. Aria Care Partners Acquires Coronado Dental to Expand On-Site Clinical Services in Arizona via its financial sponsor Serent Capital Aria Care Partners, a leading provider of onsite ancillary medical services for skilled nursing facilities, has acquired Coronado Dental. This acquisition marks Aria’s entry into the Arizona market. Aria Care Partners, which is backed by private equity investment, focuses on delivering dental, vision, hearing, and podiatry services directly to residents in long-term care facilities. By acquiring Coronado Dental, Aria expands its footprint and reinforces its position as a dominant player in the specialized geriatric clinical services sector. The deal highlights the consolidation of fragmented ancillary care providers under larger, PE-backed management platforms. (Link)
  7. Blackstone-Backed (NYSE: BX) Chartis Acquires Health Tech Firm Leap AI The Chartis Group, a healthcare advisory and analytics firm backed by Blackstone (NYSE: BX), has acquired Leap AI. Leap AI specializes in healthcare-specific artificial intelligence automation, focusing on streamlining clinical and administrative workflows. This acquisition allows Chartis to integrate advanced AI capabilities into its consulting services, helping hospital systems improve operational efficiency. For Blackstone, this move represents a continued investment in “applied AI” within the healthcare sector, moving beyond general software into tools that solve specific provider pain points. The deal highlights the aggressive expansion of tech-enabled consulting platforms. (Link)
  8. WELL Health (TSX: WELL) Subsidiary WELLSTAR Acquires Two Billing Platforms to Expand National Footprint WELLSTAR, a subsidiary of WELL Health Technologies Corp. (TSX: WELL), has completed the acquisition of two strategic billing and back-office service providers. These acquisitions expand WELL’s national billing platform, which now serves medical professionals across six Canadian provinces. WELL Health continues its “buy-and-build” strategy, acquiring fragmented healthcare IT and billing services to create a unified, tech-enabled provider network. By scaling its billing division, WELL increases its recurring revenue and strengthens its position as the largest owner-operator of outpatient clinics in Canada, providing essential administrative infrastructure to thousands of physicians. (Link)
  9. James River Home Health Acquires Golden Rule Hospice to Expand End-of-Life Care Services James River Home Health and Hospice has completed the acquisition of Golden Rule Hospice. This strategic move expands James River’s service area and strengthens its specialized hospice care offerings. The acquisition is part of James River’s effort to build a comprehensive home-based care network that covers both skilled home health and end-of-life services. As the demand for aging-in-place solutions grows, regional providers like James River are increasingly acquiring boutique hospice agencies to achieve better economies of scale and improve clinical outcomes through standardized care models. (Link)
  10. Loma Linda University Health and Kara Health Form Joint Venture for New Hospice Agency Loma Linda University Health (LLUH) has partnered with Kara Health to launch a joint venture called Loma Linda University Hospice. Kara Health is a tech-enabled home care and hospice provider. This partnership combines LLUH’s clinical excellence with Kara Health’s proprietary technology platform to provide high-quality, data-driven end-of-life care. The joint venture aims to improve patient transitions from the hospital to the home and enhance the palliative care experience through remote monitoring and streamlined communication. This model illustrates the growing trend of health systems partnering with startups to modernize home health. (Link)
  11. Palladium Equity Partners Acquires Majority Stake in DME Express from Waypoint Capital Palladium Equity Partners, LLC has announced its acquisition of a majority interest in DME Express, a leading provider of medical equipment services to the hospice industry. The stake was acquired from Waypoint Capital Partners. DME Express specializes in high-touch delivery and management of durable medical equipment (DME), primarily serving hospice and post-acute care facilities. Palladium’s investment is aimed at accelerating the company’s geographic expansion and enhancing its service capabilities. This transaction underscores the increasing interest from private equity in specialized logistics and equipment providers within the value-based care and end-of-life care sectors. (Link)
  12. SportsMed Physical Therapy Expands to 54 Clinics with New Connecticut Locations SportsMed Physical Therapy, a leading provider of physical therapy, chiropractic, and acupuncture services, has opened two new clinics in Connecticut. These openings bring the company’s total to 54 locations across New Jersey and Connecticut. SportsMed, which has received investment from private equity firms, continues to pursue a rapid “de novo” growth strategy alongside strategic acquisitions. The company focuses on a multidisciplinary approach to musculoskeletal health. This expansion reflects the high investor interest in the physical therapy sector due to its predictable revenue streams and the increasing demand for non-invasive pain management solutions. (Link)
  13. Allina Health to join Sutter Health in $26B proposed transaction in Strategic Realignment Allina Health has released a strategic announcement regarding its long-term operational and investment plan for its Minnesota-based health system. The plan includes a focus on clinical service realignment and infrastructure investment to support high-growth areas like cardiovascular and oncology care. While not a sale of the company, the announcement details strategic capital allocations aimed at improving financial stability and patient access. This news is critical for investors monitoring the financial health of non-profit systems and their shift toward outpatient-focused care models in a challenging economic environment for hospitals. (Link)
  14. Providence Explores Strategic Options Including Sale of Providence Health Plan Providence, one of the largest non-profit health systems in the U.S., has announced it is exploring strategic options for the sale of its Providence Health Plan (PHP) division. PHP is a regional health insurer serving hundreds of thousands of members in Oregon and Washington. This potential divestiture is part of Providence’s effort to shore up its balance sheet and focus resources on its core hospital operations. A sale would likely attract interest from major national insurers or private equity groups seeking a foothold in the Pacific Northwest insurance market. (Link)
  15. Valir Health Expands Senior Care Presence in Oklahoma City Valir Health has announced the acquisition of a prominent senior care facility in Oklahoma City, continuing its expansion in the post-acute care and geriatric services sector. Valir Health provides a range of services including inpatient rehabilitation, hospice care, and billing solutions. This acquisition is part of Valir’s broader strategy to consolidate senior living and rehabilitation services within the Oklahoma region. By integrating this new facility, Valir aims to improve care coordination for the elderly population. The deal reflects a regional trend of mid-sized healthcare companies expanding their physical footprint to meet growing geriatric demand. (Link)

Venture Deals

  1. Unnatural Products Raises $45 Million Series B Led by Nextech Invest and Frazier Life Sciences with participation from Northpond Ventures, Cool Springs Financial, and others to Advance Peptide Therapeutics Unnatural Products (UNP), a biotech firm specializing in macrocyclic peptide therapeutics, has secured $45 million in Series B financing. The round was led by Nextech Invest and Frazier Life Sciences, with participation from Northpond Ventures, Cool Springs Financial, and others. The company uses a platform that combines AI and medicinal chemistry to create “unnatural” macrocycles that can hit difficult-to-target intracellular proteins. The capital will be used to advance its lead oncology programs into the clinic and expand its platform capabilities. This funding highlights continued investor confidence in AI-driven drug discovery platforms targeting previously “undruggable” pathways. (Link)
  2. Conduit Health Raises $17 Million Series A Led by Drive Capital to Expand AI-Powered DME Access Conduit Health has raised $17 million in Series A funding led by Drive Capital. Conduit Health operates an AI-powered platform designed to streamline access to Durable Medical Equipment (DME). The platform connects healthcare providers, payers, and suppliers to automate the ordering and fulfillment process, which is traditionally fragmented and manual. The investment will be used to scale the company’s technology and expand its market presence. This deal underscores the venture capital interest in solving administrative bottlenecks within the home health and medical supply chain using modern software-as-a-service (SaaS) models. (Link)
  3. Verily Secures $300 Million Investment Led by Alphabet (NASDAQ: GOOGL) to Advance Precision Health AI Verily, the life sciences subsidiary of Alphabet (NASDAQ: GOOGL), has secured a $300 million investment to accelerate its precision health AI strategy. This funding round, supported by parent company Alphabet and other institutional investors, will focus on scaling Verily’s data-driven clinical research and care management solutions. The company aims to use the capital to further integrate artificial intelligence into its “Lightship” clinical trial platform and its chronic condition management tools. This massive investment signals Google’s long-term commitment to becoming a dominant player in the convergence of big data, AI, and clinical healthcare. (Link)
  4. Turquoise Health Raises $40 Million Series B Led by Adams Street Partners with participation from Andreessen Horowitz (a16z) and BoxGroup to Power Healthcare Price Transparency Turquoise Health, a healthcare pricing platform, has raised $40 million in Series B funding led by Adams Street Partners, with participation from Andreessen Horowitz (a16z) and BoxGroup. Turquoise Health provides software that enables hospitals and payers to comply with price transparency regulations and manage data-driven contracts. The company intends to use the funds to expand its “ClearContract” platform, which automates the negotiation and management of payer-provider contracts. This investment highlights the growing importance of data transparency tools as healthcare shifts toward value-based care and more complex reimbursement models. (Link)
  5. Condor Software Raises $24 Million Series A Led by Bessemer Venture Partners with participation from Casdin Capital and existing investors for Clinical Trial Finance Management Condor Software has secured $24 million in Series A funding led by Bessemer Venture Partners, with participation from Casdin Capital and existing investors. Condor Software provides a specialized financial management platform for biotech companies to track and manage the complex costs associated with clinical trials. The company aims to replace manual spreadsheets with automated workflows that integrate with clinical and financial data. The new capital will be used to scale its engineering team and accelerate product development, reflecting the niche but high-value demand for fintech solutions tailored specifically to the life sciences industry. (Link)
  6. RAAPID Secures Series A Extension Led by Celesta Capital to Scale Neuro-Symbolic AI for Medical Coding RAAPID has secured a Series A extension funding round led by Celesta Capital to scale its “Neuro-Symbolic” AI-powered medical coding and risk adjustment platform. The company’s technology helps healthcare providers and insurers automate the complex process of clinical documentation and coding, ensuring accurate reimbursement. By combining deep learning with symbolic AI, RAAPID aims to provide higher accuracy and transparency than traditional LLM models. The funding will support geographic expansion and further R&D. This deal illustrates the shift toward specialized, high-accuracy AI tools for administrative healthcare tasks where error margins are critical. (Link)
  7. Health Universe Raises $6 Million Seed Round Led by Eniac Ventures for AI Agents in Medical Workflows Health Universe, a platform for developing and deploying AI “agents” for medical workflows, has raised $6 million in a seed funding round led by Eniac Ventures. The platform allows developers and clinicians to collaborate on AI models that automate specific clinical tasks, such as surgery scheduling or pathology reporting. Health Universe provides the infrastructure for hosting and running these models securely in a compliant environment. This investment highlights the emerging “AI-as-a-Service” model within healthcare, where platforms provide the tools for specialized, agentic AI to be integrated into daily hospital operations. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Mar 16th, 2026

LECO_Weekly-Healthcare-News_3-16-2026Download
  1. Aveanna Healthcare Holdings (NASDAQ: AVAH) to acquire Trivest-backed Family First Homecare, expanding pediatric home care footprint and leveraging cash and credit facilities for accretive growth via its financial sponsors Bain Capital and J.H. Whitney Capital Partners Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) agreed to acquire Family First Holding, LLC, a multi-state pediatric home care provider backed by growth investor Trivest Partners since 2021, in a strategic platform expansion deal. The transaction, funded through cash on hand and Aveanna’s existing short-term credit facility, is expected to close in Q2 2026 subject to customary conditions, underscoring lender confidence in the issuer’s credit profile. For Trivest, the exit crystallizes value created since its minority investment, while Aveanna investors gain access to 27 locations across seven states and deeper exposure to high-acuity, home-based pediatric care. Management highlights the acquisition as aligned with Aveanna’s strategy to scale specialized care models and deliver enhanced value to payors and stakeholders. (Link)
  2. Veeva Systems (NYSE: VEEV) pays $100 million for AI brand engagement platform Ostro, enhancing life sciences commercial cloud offering Veeva Systems Inc. (NYSE: VEEV) has acquired Ostro, an AI-powered brand engagement platform, for $100 million to strengthen its commercial suite for life sciences clients. The acquisition integrates AI-driven customer engagement and personalization into Veeva’s CRM and marketing stack. Shareholders gain incremental growth opportunities as pharma and biotech customers increase digital and AI spend. The all-cash deal aligns with Veeva’s strategy of adding focused applications that drive higher wallet share and stickiness across large enterprise accounts. (Link)
  3. Medtronic (NYSE: MDT) to acquire neurovascular device company, Scientia Vascular, for $550 million, bolstering high-growth stroke and neuro interventions pipeline.Medtronic plc (NYSE: MDT) has agreed to acquire a neurovascular device company, Scientia Vascular, for approximately $550 million, targeting expansion in stroke and neuro-interventional therapies. The acquisition enhances Medtronic’s innovation pipeline and positions the company to compete more aggressively in high-growth, procedure-driven markets. Equity investors in Medtronic gain exposure to a differentiated product portfolio that can support long-term revenue growth and margin expansion. The transaction will likely be funded through Medtronic’s balance sheet and is consistent with its strategy of bolt-on acquisitions in key therapy areas. (Link)
  4. RadNet (NASDAQ: RDNT) to acquire AI radiology company Gleamer, advancing imaging AI capabilities and strengthening diagnostic services moat. RadNet, Inc. (NASDAQ: RDNT) has agreed to acquire Gleamer, an AI radiology company, to integrate advanced AI tools into its large-scale imaging network. The acquisition is expected to enhance diagnostic accuracy, workflow efficiency, and throughput across RadNet’s centers. Equity investors view the move as strategic positioning in AI-enabled diagnostics, potentially improving margin structure and differentiation against competitors. The deal also gives Gleamer’s technology a scaled deployment channel, increasing data volume and algorithm performance over time. (Link)
  5. MedImpact Holdings acquires MHW Benefit Partners and MSL Captive Solutions to build integrated risk and pharmacy benefits platform for self-funded employers. MedImpact Holdings, Inc., a leading independent health solutions and pharmacy benefit company, acquired MHW Benefit Partners and MSL Captive Solutions to expand its suite of alternative risk-financing offerings for employer clients. The deal broadens MedImpact’s capabilities into captives and stop-loss insurance, enabling small and mid-sized employers to access structures historically used by large self-insured groups. Investors in MedImpact gain exposure to higher-margin, capital-efficient risk-management services that complement the core PBM and clinical programs. The acquisitions are expected to drive cross-sell opportunities across TPAs, transparent networks, drug savings, and member care solutions, deepening client stickiness and recurring revenue. (Link)
  6. Prospect Medical Holdings sells final Crozer hospital for $1 million, marking distressed exit from Pennsylvania market and transfer to local nonprofit sponsor. Prospect Medical Holdings has completed the divestiture of its final Crozer Health hospital for approximately $1 million, effectively exiting its troubled Pennsylvania hospital portfolio. The low valuation underscores ongoing financial distress and operational challenges in safety-net acute care assets, impacting prior private equity investors in the platform. The facility transitions to a local nonprofit sponsor, shifting governance away from financial sponsors toward mission-driven community operators. Lenders and bondholders will monitor post-transaction capital commitments and turnaround plans as the new owner seeks to stabilize operations and address deferred investment needs. (Link)
  7. CSG.BIO partners with and Asian Egg Bank, adding specialized fertility assets backed by Corbel to its global reproductive health platform. CSG.BIO has entered a partnership with Hanabusa IVF and Asian Egg Bank, acquiring a specialized fertility clinic and donor egg bank focused on Asian patients to expand its reproductive health platform. The deal is supported by capital from Corbel, providing growth funding to scale the mini-IVF and donor egg offerings across new markets. Investors in CSG.BIO gain differentiated assets in a high-growth, cash-pay fertility segment with strong patient demand. The transaction reflects continued private equity and sponsor interest in fertility platforms with unique clinical models and demographic specialization. (Link)
  8. BV Investment Partners takes stake in Moxe Health, backing healthcare data exchange platform in value-based care ecosystem. BV Investment Partners has made an investment in Moxe Health, a healthcare data exchange and interoperability platform focused on payor-provider connectivity. The capital infusion will support product development and commercial expansion as value-based care models require richer, real-time data flows. For BV’s limited partners, the deal offers exposure to a high-growth, recurring revenue SaaS model in healthcare IT infrastructure. Moxe plans to leverage the partnership to accelerate integrations with payors and providers, enhancing network effects and stickiness. (Link)
  9. MedCare Express sold to physician group AMKY Health CT, LLC, transitioning a scaled urgent and primary care practice to new clinical owners. MedCare Express, an integrated urgent and primary care center serving over 30,000 active patients in the Greater Hartford area, has been sold to private physician practice group AMKY Health CT, LLC. Founded in 2007, MedCare Express has built a strong community footprint and recurring patient base, making it an attractive cash-flow asset for physician investors. The buyer plans to support growth while preserving quality standards, signaling a long-term, clinical-operator-led strategy rather than a near-term financial engineering approach. Existing stakeholders benefit from continuity of care and potential service expansion under new ownership. (Link)
  10. Baptist Health to acquire South Arkansas Regional Hospital in El Dorado, extending nonprofit system’s regional footprint and strengthening community care. Baptist Health has signed an agreement to acquire South Arkansas Regional Hospital in El Dorado, Arkansas, adding a key community hospital to its regional nonprofit health system. The acquisition brings the hospital under a larger balance sheet, providing access to capital for facility upgrades and service expansion. For bondholders and donors supporting Baptist Health, the transaction represents a strategic bet on stabilizing rural and small-market acute care. Local stakeholders are expected to benefit from integration into Baptist’s broader clinical network and potential economies of scale in operations and procurement. (Link)
  11. HouseWorks acquires A Caring Experience, scaling private-pay home care footprint and consolidating in the New England market via its financial sponsors InTandem Capital Partners and BPEA Private Equity HouseWorks, a home care provider backed by institutional investors, has acquired A Caring Experience to deepen its presence in the New England home care market. The deal adds local scale, enhances caregiver capacity, and broadens referral relationships in a competitive private-pay and Medicaid-waiver environment. Investors in HouseWorks are positioning for demographic tailwinds and further roll-up opportunities in non-medical home care. The combination is expected to generate operating synergies across scheduling, back-office functions, and recruitment, improving margin profile over time. (Link)
  12. Dynamic Access acquires PICC STAT in Minnesota, expanding vascular access services footprint for clinical and financial sponsors via its financial sponsor RiverGlade Capital Dynamic Access has acquired PICC STAT, a Minnesota-based vascular access provider, in a tuck-in acquisition to grow its specialized PICC and vascular access services network. The deal strengthens Dynamic Access’s regional coverage, allowing payors and health systems to rely on a larger contracted network for on-demand vascular access. Financial sponsors backing outsourced clinical service platforms benefit from increased density, which supports higher route efficiency and utilization. The acquisition underscores ongoing consolidation in niche procedural services where scaled operators can secure better payer contracts and operating leverage. (Link)
  13. Residential Home Health and Hospice acquires Covenant, building scale in home health and hospice across regional markets for sponsor-backed platform. Residential Home Health and Hospice has announced the acquisition of Covenant, adding a substantial home health and hospice footprint to its existing platform. The deal expands the provider’s presence across multiple states, increasing patient census and strengthening referral networks. Sponsor investors behind Residential are pursuing a scale and density strategy in post-acute care, where larger platforms can better manage labor, compliance, and payor relationships. The transaction positions the combined organization to capture more value in value-based and episodic payment arrangements. (Link)
  14. Health Recovery Solutions acquires Rimidi, expanding remote care programs and chronic disease management capabilities for digital health investors. Health Recovery Solutions has acquired Rimidi to broaden its remote patient monitoring and chronic disease management solutions. The combined platform will offer providers and payors an integrated suite for virtual care, data analytics, and patient engagement. Investors see the transaction as consolidation in a crowded remote monitoring space, aiming to reach sustainable scale and differentiated outcomes data. The deal positions the company to participate more fully in value-based arrangements tied to chronic condition control. (Link)
  15. Guideway Care acquires Waypoint Healthcare Solutions, expanding patient navigation and care coordination platform for payor and provider sponsors. Guideway Care has acquired Waypoint Healthcare Solutions to enhance its patient navigation and care coordination capabilities. The transaction deepens Guideway’s relationships with payors and providers seeking to reduce avoidable utilization and improve outcomes. Financial sponsors backing navigation and care-management platforms expect enhanced cross-sell and contract win rates from the expanded offering. The combined entity is positioned to integrate analytics, staffing, and workflow tools under a single, scalable model. (Link)
  16. Centerpoint Health Winchester acquires local medical practice, expanding primary care capacity under community health center sponsorship. Centerpoint Health Winchester has announced the acquisition of a local medical practice, adding providers and patient volume to its community health operations. The deal supports Centerpoint’s mission-driven growth strategy, bringing more primary care access under a single organizational umbrella. For grantors and community-focused investors, the transaction aligns with population health and access objectives rather than pure financial returns. The additional capacity may improve economies of scale in administration and payer contracting for the center. (Link)
  17. ECU Health agrees to sell home health and hospice unit to Liberty, pending state review, rebalancing portfolio toward core acute services ECU Health has agreed to sell its home health and hospice operations to Liberty, subject to state regulatory review. The divestiture allows ECU Health to refocus capital and management attention on its core acute care and hospital assets. Liberty, a home health and hospice operator, gains additional scale and access to new markets, enhancing network density for its investors and lenders. The transaction continues a broader trend of health systems exiting ancillary service lines to specialized operators. (Link)
  18. Sonida Senior Living (NYS:SNDA) completes $1.8 billion strategic merger with CNL Healthcare Properties, deepening senior housing scale and institutional investor backing. Sonida Senior Living has closed a strategic merger with non-traded REIT CNL Healthcare Properties Inc., valuing the combined senior housing platform at approximately $1.8 billion and significantly increasing real estate scale for equity holders. The transaction gives Sonida access to a larger portfolio of senior living communities and a broader institutional capital base anchored by CNL’s healthcare-focused investors. The combined platform is positioned to pursue operational efficiencies, refinancings, and future portfolio optimization to enhance returns. Equity stakeholders in both entities gain from diversification across markets and care levels, while debt providers benefit from greater asset backing. (Link)
  19. Biomemory acquires Catalog Technologies, preparing DNA data storage deployment in data centers in H2 2026 for deep-tech backers. DNA data storage startup Biomemory has acquired Catalog Technologies, consolidating IP and capabilities to commercialize DNA-based data storage solutions. The combined company plans data center deployments in the second half of 2026, targeting hyperscale and enterprise customers seeking ultra-dense, long-term storage. Deep-tech and climate-conscious investors see potential in DNA storage’s low energy footprint compared to traditional media. The acquisition accelerates time-to-market and strengthens Biomemory’s competitive position in a nascent but strategically important storage category. (Link)
  20. Aditxt (NAS: ADTX) buys Ignite Proteomics for $36 million in preferred stock and secures $2.88 million note financing, strengthening precision medicine portfolio. Aditxt has acquired Ignite Proteomics in a stock-based transaction valued at $36 million in preferred equity, alongside securing $2.88 million in note financing. The deal brings proteomics capabilities into Aditxt’s precision medicine and immune monitoring portfolio, offering investors upside in biomarker-driven platforms. The structure, heavily equity-based with incremental debt, reflects a capital-efficient approach for a growth-stage company. Noteholders gain exposure to potential value inflection from integration and commercialization of Ignite’s technologies. (Link)

Venture Deals

  1. Amigo AI Secures $11 Million Series A Led by Madrona to Scale Patient-Facing Clinical AI Agents with significant participation from Optum Ventures Amigo AI has successfully raised $11 million in a Series A funding round led by Madrona, with significant participation from Optum Ventures. This capital infusion brings the company’s total funding to $17 million, following a previous seed round supported by General Catalyst and GSV Ventures. The investment is earmarked for the expansion of Amigo’s “digital residency” platform, which trains AI agents in simulated clinical environments to ensure a 100% safety pass rate before patient interaction. For venture investors, Amigo represents a high-growth opportunity to address the global healthcare workforce shortage by automating complex clinical workflows like triage and care navigation across 100+ languages. (Link)
  2. Arya Secures $21 Million Series A to Scale Relationship OS Platform for Modern Couples Arya has successfully raised $21 million in a Series A funding round led by Canvas Ventures, with participation from existing investors including General Catalyst and SV Angel. This capital injection is aimed at accelerating the development of its “Relationship OS,” a technology platform designed to help couples navigate emotional, financial, and logistical complexities through data-driven insights. For venture investors, the deal represents a strategic entry into the rapidly growing “Family Tech” and wellness space, leveraging AI to provide personalized coaching and conflict-resolution tools. The funding will support product engineering and the expansion of Arya’s user base as it seeks to define a new category of proactive mental health and relationship maintenance. (Link)
  3. Carefam Raises $10.5 Million to Scale AI-Driven Healthcare Recruitment Platform led by Pitango Venture Capital Carefam has successfully raised $10.5 million in a new funding round, bringing its total capital raised to $14 million. The investment is aimed at expanding its specialized conversational AI platform, which automates the end-to-end hiring process for hospitals, long-term care facilities, and home care providers. For venture investors, Carefam addresses the critical global healthcare labor shortage by streamlining credential screening, interview scheduling, and onboarding through vertically integrated AI agents. The funding will allow the company to enhance its technology and scale its operations to help healthcare HR departments reduce administrative friction and accelerate the placement of essential clinical staff. (Link)
  4. Qualified Health Eyes Series A Funding Following $30 Million Seed Round Led by SignalFire, Healthier Capital, and Town Hall Ventures Qualified Health, a pioneer in healthcare orchestration, is reportedly preparing for a Series A funding round to scale its AI-driven platform that streamlines clinical and administrative workflows. This follows a substantial $30 million seed investment led by SignalFire, Healthier Capital, and Town Hall Ventures, which allowed the company to deploy its “operating layer” across major systems like University of Texas and Jefferson Health. For venture investors, the startup represents a high-potential infrastructure play that integrates with EHRs to automate summarization and prior authorization. Potential new investors such as NEA and General Catalyst are being watched as the company targets a nine-figure valuation while navigating rigorous generative-AI safety and regulatory hurdles. (Link)
  5. Translucent Secures $27 Million Series A Led by GV (Google Ventures) to Revolutionize Healthcare Financial Operations Translucent has closed a $27 million Series A funding round led by GV, with participation from existing investors including Benchmark and Unusual Ventures. This capital injection is dedicated to scaling the company’s AI-driven financial orchestration platform, which targets the “existential financial crisis” facing hospitals by automating complex revenue cycle and accounts payable workflows. For venture investors, Translucent represents a critical infrastructure play that addresses thin hospital margins through autonomous financial intelligence. The funding will be used to accelerate product development and expand the company’s footprint across health systems seeking to replace manual, error-prone administrative tasks with real-time, transparent financial data management. (Link)